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ABSTRACT
Murphy, Jesse R. Ph.D, Purdue University, May 2016. Mechanistic Characterization of
Acetic Acid Aesistance Enzymes of Acetobacter Aceti. Major Professor: T.J. Kappock.
Acetobacter aceti (A. aceti) is a Gram-negative, acidophilic bacterium that is used
for the industrial production of acetic acid from ethanol. Oxidation of ethanol by
membrane-bound oxidoreductases provides energy for A. aceti and the production of
high concentrations of acetic acid is an effective defense mechanism. Acetic acid diffuses
through cell membranes at low pH and effectively kills many bacteria, including E. coli, at
low millimolar concentrations. The ability of A. aceti to thrive in molar concentrations of
acetic acid is partially due to the twin subjects of this thesis, the acetic acid resistance
factors AarA (citrate synthase, AaCS) and AarC (succinyl-CoA:acetate CoA-transferase).
AarC and CS exploit the distinct properties of the thioester moiety in acetyl-CoA
(AcCoA) to catalyze different reversible reactions. AarC takes advantage of the relatively
high leaving group potential of the CoA thiolate (anionic or RS– form) to transfer the acetyl
moiety of AcCoA to an active site glutamate. In contrast, CS uses the relatively acidic
carbon adjacent to the thioester moiety to catalyze a Claisen/aldol condensation reaction
that forms a new carbon-carbon bond. Class I CoA-transferases such as AarC produce
acylglutamyl anhydride intermediates that undergo attack by the CoA thiolate on one of

xii

its

two

carbonyl

carbon

atoms,

forming

distinct

internal

or

external

tetrahedralintermediates less than 3 Å apart. In this study, crystal structures were used to
examine the role of the internal oxyanion hole residue Asn347 and the highly conserved
elements of the external oxyanion hole.
First, a structure of the active mutant AarC-N347A bound to CoA revealed both
solvent substitution for the deleted carboxamide and displacement of the adjacent
Glu294. This indicates that Asn347 both polarizes and orients the essential glutamate
Glu294.
Second, AarC was crystallized with the nonhydrolyzable AcCoA analogue
dethiaacetyl-CoA (AcMX) in an attempt to trap a closed enzyme complex containing a
stable analogue of the external oxyanion intermediate. One active site contained an
acetylglutamyl anhydride adduct and a truncated AcMX, an unexpected result hinting at
what would have been an unprecedented cleavage of the ketone moiety into an acetyl
group and the CoA analogue MX. Solution studies confirmed that AcMX decomposition is
accompanied by production of near-stoichiometric acetate, in a process that seems to
depend on microbial contamination but not AarC.
Authentic MX was synthesized to evaluate the hypothesis that it is derived from
AcMX. A crystal structure of AarC bound to MX showed complete closure of one active
site per dimer but no acetylglutamyl anhydride, even for crystals grown in the presence
of exogenous acetate. These findings imply that AcMX degradation results in the
production of an activated acetyl donor; a working hypothesis involving ketone oxidation
is offered. Moreover, the ability of MX to induce full active site closure suggests that it

xiii

subverts a system used to impede inappropriate active site closure on unacylated CoA.
The remainder of this thesis concerns the enzyme CS, an essential part of central
metabolism in aerobes and many other organisms. The CS reaction comprises two
successive reactions: a Claisen/aldol condensation of AcCoA and oxaloacetate (OAA) that
forms citryl-CoA (CitCoA), and CitCoA hydrolysis. Protein conformational changes that
close the active site assemble a catalytically competent condensation active site. The 2.2
Å resolution crystal structure of CS from the thermoacidophile Thermoplasma

acidophilum (TpCS) fused to a C-terminal hexahistidine tag (TpCSH6) reported here is an
open structure that, when compared with several liganded TpCS structures, helps to
define a complete path for active site closure.
Hydrogen-deuterium exchange (HDX) reactions can be used to study the critical
proton transfer required for condensation. In D2O, both TpCS•OAA and AaCS•OAA
catalyze rapid HDX in AcMX. Fluorescence “dequenching” that occurs upon addition of
AcMX to OAA complexes of CS forms that possess a suitable (reporter) Trp is the result of
the destruction of the polarized OAA carbonyl during condensation. TpCS•OAA converts
AcMX to the binary condensation product complex TpCS•CitMX, which means that more
than one event could account for the introduction of a deuterium atom that results in
HDX. In contrast, AaCS•OAA appears to stabilize the ternary pseudo-Michaelis complex
AaCS•OAA•AcMX, with no evidence of condensation. Mass spectrometric and isotope
effect studies are used to define the kinetic mechanism of AaCS•OAA catalyzed HDX.
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CHAPTER 1. BACKGROUND AND INTRODUCTION
1.1

Perspective

New bio-based strategies to implement large-scale replacement of petroleumderived chemical matter have the potential to transform global economic systems. An
approach called synthetic biology adds manmade evolutionary selection to create new
processes and materials from existing enzymes. A key step in this process is to investigate
structure/function relationships of diverse enzymes with the hope of altering substrate
specificity and making new products.
In the cell, acyltransfer and carbon-carbon bond forming condensation reactions
are commonly used to enlarge small molecules. Linking otherwise unreactive
carboxylates to coenzyme A (CoA) through a thioester increases reactivity in one of two
ways. First, the CoA moiety can facilitate acyltransfer reactions by acting as an effective
leaving group due to the relatively low pKa of the incipient thiolate. This type of acyl
activation is required in the biosynthesis of phospholipids, neurotransmitters, and diverse
acyl-CoAs. Second, the thioester linkage in acetyl-CoA (AcCoA) increases the acidity of the
adjacent α-carbon. This type of activation is important because the first chemical step in
condensation reactions is the difficult deprotonation of a carbon acid, which formally
produces a highly reactive carbanion intermediate. The acyl-CoA thioester is a single
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functional group that allows two main types of otherwise difficult chemical reactions to
occur under physiological conditions. Biosynthesis of AcCoA by most bacteria requires an
initial energy investment. Acetate must be activated, often by acetate kinase (AK) (Figure
1.1a) and ATP-dependent phosphorylation. Formation of AcCoA from acetyl-phosphate
and CoA is then catalyzed by phosphotransacetylase (PTA). Alternatively, AcCoA can be
synthesized from acetate, ATP, and CoA by one enzyme, AcCoA synthetase (ACS) (Figure
1.1b). ATP usage in this way is a worthwhile investment because of the diverse
functionality of AcCoA and both acyl- transfer and condensation reactions allow for the
recovery and recycling of CoA.
Citrate synthase (CS) catalyzes the condensation of AcCoA and OAA and hydrolysis
of a citryl-CoA intermediate. There has been strong selective pressure to ensure extreme
specificity as any AcCoA hydrolase activity would be metabolically detrimental to the cell.
It is currently unknown how CS is able to very effectively differentiate and specifically
hydrolyze citryl-CoA but not the substrate AcCoA.

Figure 1.1 Synthesis of AcCoA. The formation of AcCoA by AK/PTA and ACS requires ATP.
Acetobacter aceti uses a variant citric acid cycle to remove excess cytoplasmic acetate.
Acetic acid is a cell permeable acid produced by acetic acid bacteria (AAB) that acidifies
the cytoplasm and disrupts the proton gradient thereby killing competing microbes
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(Francois et al., 2006). Acetobacter aceti (A. aceti) is a particularly acid tolerant AAB that
is widely used in the commercial production of vinegar from ethanol (Asai, 1968). A. aceti
has evolved extreme internal acetate tolerance that is largely attributed to increased
inherent protein acid stability, expressing an acetate: proton antiporter, and expression
of acetic acid resistance genes aarABC (Matsushita et. al., 2005; Nakano et. al., 2006;
Fukaya et. al., 1990; Mullins et. al., 2008). AarA is a citrate synthase (AaCS), SixA (produced
by a genetic region originally designated aarB) is a transcriptional regulator thought to
activate flux through the citric acid cycle, and AarC is an acyl-CoA transferase (Francois et.
al., 2006; Fukaya et al., 1990; Mullins et al., 2008). These enzymes work together to
process the constant influx of acetate experienced by A. aceti. AarC catalyzes the
formation of AcCoA from succinyl-CoA and free acetate or acetic acid. Acetate thereby
has a direct path into the CAC in the form of AcCoA by condensation with OAA catalyzed
by CS. In this variant CAC, CoA is recovered and excess acetate is lost to diffusion upon
“overoxidation” to CO2 (Mullins et al., 2008).
AarC catalyzes the formation of AcCoA from succinyl-CoA and acetate. CoA-transferases
catalyze the reversible transfer of CoA from acyl-CoA thioesters to free carboxylates in
order to increase acyl-CoA diversity. AarC is a succinyl-CoA: acetate CoA-transferase that
allows for the direct incorporation of acetate into the CAC of A. aceti (Mullins and Kappock
2012). Class I CoA-transferase such as AarC catalyze CoA transfer reactions through
multiple covalent adducts at the active site glutamate (Figure 1.2) (Hersh and Jencks
1967a-c; Solomon and Jencks 1969; Pickart and Jencks 1979; White and Jencks 1976).
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In the forward direction, initial nucleophilic attack on the succinyl-CoA substrate by
Glu294 results in the formation of the external oxyanion intermediate stabilized in a novel
oxyanion hole composed of Gly388 NH and the CoA N2’’ (Mullins and Kappock, 2012). The
resulting CoA thiolate acts as a leaving group forming a succinylglutamyl anhydride. CoA
does not exchange and is free to attack the internal succinylglutamyl anhydride carbonyl
forming the internal oxyanion that is proposed to be stabilized by Asn347 (White and
Jencks, 1976; Jacob et al., 1997). Upon the formation of the glutamyl- CoA thioester,
succinate and free acetate are free to exchange and the reverse reaction occurs ultimately
resulting in the formation of AcCoA.

Figure 1.2. The forward half-reaction catalyzed by AarC. AarC catalyzes the freely
reversible transfer of CoA between succinate and acetate. In the forward direction
succinate is generated upon formation of the glutamyl-CoA thioester. Acetate exchanges
with succinate and the reverse reaction occurs, ultimately forming AcCoA.

Jencks argued that for enzyme catalyzed reactions to occur it is not sufficient for
enzymes to only stabilize the transition state (Jencks, 1975). In order to more easily reach
the transition state, both the enzyme-substrate (ES) and enzyme-product (EP) complexes
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must be destabilized by adding steric strain, desolvation of the active site, and/or
decreasing entropy by holding the substrate in the proper orientation for catalysis.
Enzymes must “pay” for this destabilization of the ground state by harnessing the free
energy of the non-covalent binding interactions (Jencks, 1987).
Acyl-CoA transferases are an ideal model system for studying how distal, noncovalent enzyme-substrate interactions provide the driving force for catalysis. Kinetic and
thermodynamic analysis of acyl-CoA transferases suggest that non-covalent interactions
with the ADP moiety of acyl-CoA substrates is responsible for the observed rate
enhancements in acyl-transfer (White and Jencks, 1976; Moore and Jencks, 1982).
Furthermore, an intact acyl-CoA substrate is required to effectively transmute the binding
energy from distal enzyme-substrate interactions into rate accelerations (Fierke and
Jencks, 1982).
Due to the high concentration of intracellular acetate, AarC is under strong
selective pressure forcing this CoA-transferase to have unusually high substrate specificity
rapid kinetics (Mullins and Kappock, 2012). Crystal structures of AarC frozen in various
stages of the reaction were later solved and were consistent with the Jencks model of
catalysis (Mullins and Kappock 2012). Active site closure upon binding to a valid acylsubstrate accelerates catalysis by simultaneously constituting the external oxyanion hole,
contorting the thioester into a Bürgi-Dunitz configuration, and enforcing a conformation
that stabilizes acylglutamyl anhydride relative to the Michaelis complex (Bürgi et al.,
1973). Previous attempts to crystallize the closed enzyme-substrate complex has required
mutation of active site residues (Mullins and Kappock, 2012). To date, the closed
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conformation of wild type AarC bound to substrates or analogues has not been observed.
Crystal structures indicate AarC E294A bound to CoA adopts the closed conformation.
However, mutation of Glu294 to alanine not only shortens the Glu side chain providing
increased active site volume but also removes hydrogen bonding potential with the CoA
thiol in the active site. It is therefore possible that hydrogen bonding between the CoA
thiol and the Glu carboxylate prevents active site closure. The inability to structurally
examine the closed form of the wild type enzyme has been a major hurdle preventing
study of the unique AarC active site, specifically, the formation of adjacent oxyanion holes
(Figure 1.2).
AaCS catalyzes proton exchange without condensation. As the first enzyme in the CAC,
CS catalyzes one of the most important carbon-carbon bond forming reaction in all
aerobes. CS catalyzes the condensation between the carbonyl of OAA and the terminal
methyl group of AcCoA (Figure 1.3). The intermediate product citryl-CoA is then
irreversibly hydrolyzed to citrate and CoA, in what is typically the rate- limiting step for
the enzyme (Kurz et al., 2000; Kurz et al., 2009).
The similar appearance of the active site in CS forms from all domains of life has
led to the assumption that they all use the same chemical mechanism, despite a very high
degree of sequence divergence. CS from pig heart (PCS) or the euryarchaeon
Thermoplasma acidophilum (TpCS) are dimeric (type I) whereas CS from E. coli (EcCS) or
A. aceti (AaCS) are hexameric (type II) (Singh et al., 1970; Kurz et al., 2000; Francois et al.,
2006). AaCS was crystallized in the closed form bound to OAA and carboxymethyldethiaCoA (CMX). This confirmed that the hexameric forms consist of three protomers, each
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resembling the type I dimer, and the two types have near superimposable active sites
suggesting that the number of protein subunits does not affect the mechanism
(Remington et al., 1982; Wiegard et al., 1984; Usher et al., 1994).
The CS condensation reaction can be studied without interference from the
hydrolysis reaction using the AcCoA analogue AcMX, in which the thioester is replaced
with a ketone (Kurz et al., 2009). Condensation can be monitored directly using
fluorescence spectroscopy in both CS types that contain a reporter tryptophan (Kurz et
al., 2000; Francois et al., 2006). Substantial quenching of intrinsic tryptophan fluorescence
upon OAA binding is caused by proximity of the polarized OAA carbonyl to a semiconserved Trp residue (Kurz et al., 2005). During condensation, the OAA carbonyl is
attacked by the AcCoA enolate causing conversion of the sp2 orbital to sp3 upon formation
of citryl-CoA (Figure 1.3), effectively “dequenching” Trp fluorescence (Figure 1.3) (Kurz et
al., 2009).
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Figure 1.3. Condensation half-reaction catalyzed by AaCS. AcCoA (R is the remainder of
CoA) and OAA are shown bound in the AaCS active site. Asp371 is the base that
deprotonates the terminal methyl group of AcCoA forming the enolate intermediate.
His272 plays an orientational role and interacts with the thioester of AcCoA and the
enolate intermediate. The carbanion attacks the polarized carbonyl of OAA forming citrylCoA. CS then hydrolyzes citryl-CoA to form citrate and CoA. It is important to note that
the AcCoA analogue AcMX where the thioester sulfur is replaced with a ketone methylene
would prevent hydrolysis and thus isolate the condensation half-reaction.
The first chemical step in the condensation reaction is deprotonation of the
terminal methyl group of AcCoA, resulting in transient formation of an enolate
intermediate with strong carbanion character. Transient carbanion formation can be
monitored by hydrogen deuterium exchange (HDX) of substrate protons for solvent
deuterons (Rose, 1958). CS●OAA catalyzed HDX of the terminal methyl group of AcCoA is
not observed during turnover in D2O (Kurz et al., 2000). The non-hydrolyzable but HDX
susceptible AcCoA ketone analogue AcMX isolates the condensation reaction from the
subsequent hydrolysis but does not completely isolate the proton transfer reaction (Kurz
et al., 2009). Fluorescence dequenching is observed upon TpCS●OAA binding to AcMX,
consistent with crystallographic detection of the citryl-CoA analogue citryl-MX. Hydrolysis
of citryl-MX is not chemically possible due to the pKa of what would be the incipient
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carbanion and dissociation of citryl-MX was not observed. Instead, reverse condensation
occurs resulting in reformation of OAA and partially exchanged AcMX. It is difficult to
determine if AcMX HDX occurs before or after condensation between AcMX and OAA.
This is an important distinction because HDX prior to condensation would indicate the
reversible formation of a carbanion whereas HDX after condensation would indicate that
proton transfer and condensation are concerted. PCS may address this issue because the
equilibrium favors PCS●OAA●AcCoA over PCS●CitCoA but PCS lacks an OAA sensitive Trp
residue (Kurz et al., 2009). The work highlighted here shows that AaCS catalyzes AcMX
HDX without formation of citryl-MX and therefore is the CS form best suited to study the
critical proton transfer reaction.
1.2

Purpose

The following is a structure/function examination of two enzyme types, an acylCoA transferase (AarC) and citrate synthase (CS). AarC and AaCS are related in that they
are essential for the extreme acid tolerance of of A. aceti. Furthermore, these enzymes
must form and stabilize oxygen and carbon centered nucleophiles that are used in central
metabolism to enlarge small molecules.
Chapter 2 provides the first published and deposited unliganded structure of TpCS
and allows for detailed examination of conformational changes upon ligand binding. This
work also provides the generation and purification of a hexahistidine tagged TpCS
(TpCSH6) and the kinetic analysis to show this tag has little effect on enzyme activity. This
CS form greatly simplifies the commonly used purification protocol involving the use of
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dye ligand columns (Sutherland et. al., 1991). [The contents of Chapter 2 were published
in Murphy et. al., 2015].
Chapter 3 examines AarC active site closure and probes the assembly of adjacent
oxyanion holes. Mutagenesis of the internal oxyanion hole previously showed diminished
activity (Mullins and Kappock, 2012). The data presented here suggests that Asn347 acts
to not only stabilize the internal oxyanion but also plays a role in orienting Glu294 in the
active site. As the external oxyanion hole is comprised of the Gly388 backbone nitrogen
and the distal amide nitrogen of the substrate itself, the external oxyanion was probed
using the unreactive substrate analogue AcMX. The evidence provided in chapter 3
suggests that microbial contamination initially oxidized AcMX and allowed the product to
act as an effective AarC acylating agent. The identity of the nucleotide containing product,
after acyl-transfer, is unclear but provided the framework for future experiments. The
proposed product, MX, is a CoA analogue where the terminal thiol is replaced with a
methyl group. Crystal structures of wild type AarC bound to MX adopted the closed
conformation where AarC bound to CoA remains open. This suggests that hydrogen
bonding between the active site glutamate and the CoA thiol is responsible for
discrimination between acyl-CoA substrates and the weak inhibitor CoA. [The contents of
Chapter 3 have been submitted for review].
Chapter 4 demonstrates that AaCS can catalyze hydrogen-deuterium exchange
without condensation in the AcCoA ketone analogue AcMX. This analogue has been used
to isolate the condensation reaction in another CS form, TpCS. (Kurz et al., 2009). It was
also demonstrated that TpCS catalyzes HDX of the terminal methyl group of AcMX but
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rate constants for the condensation and reverse-condensation reaction, derived from
fluorescence “dequenching” kinetics, are much faster. Thus it is not possible to determine
if HDX occurs prior to condensation or only as the enzyme performs the reversecondensation reaction. AaCS also catalyzes HDX of the terminal methyl group of AcMX
but apparently cannot perform the subsequent condensation reaction to a detectable
extent. To date, AaCS●OAA + AcMX is the only known system to perform HDX without
condensation and therefore hydrolysis. This provides a comparatively simplified system
for the study of proton exchange in CS and shows AaCS is the ideal form to study this
reaction.
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CHAPTER 2. AN ACTIVE SITE-TAIL INTERACTION IN THE STRUCTURE OF HEXAHISTIDINETAGGED THERMOPLASMA ACIDOPHILUM CITRATE SYNTHASE

2.1

Introduction

Citrate synthase (CS) performs two sequential reactions: a reversible
condensation reaction converts acetyl coenzyme A (AcCoA) and oxaloacetate (OAA) into
citryl-CoA (CitCoA), and an irreversible thioester hydrolysis then forms citrate and CoA.
This pivotal metabolic reaction is performed by members of at least three enzyme
superfamilies (Eggerer, 1965; Gottschalk & Barker, 1966; Kobylarz et al., 2014). The CS
dimer is a classic case of induced-fit substrate binding (Srere, 1966; Bloxham et al., 1980).
OAA binding induces domain closure and the formation of an AcCoA binding site between
the large and small domains of each subunit (Remington et al., 1982; Wiegand &
Remington, 1986; Daidone et al., 2004). Since many conserved active-site residues
participate in both the condensation and hydrolysis reactions, the central CS–CitCoA
complex is expected to toggle among multiple configurations (Bayer et al., 1981). Strong
selective pressure ensures a high degree of substrate specificity: CS does not cleave
AcCoA but efficiently hydrolyzes CitCoA (Srere, 1972). A mechanism proposed for the
condensation reaction, based in part on the crystal structures of liganded complexes

Declaration of collaborative work: In this study the TpCS crystals were prepared by Stefano Donini and the structure was solved by T.
Joseph Kappock. All other experiments and analysis were done by Jesse R. Murphy. This chapter has been published and used with
permission: Murphy, J., R., Donini, S., Kappock, T.J., An active site-tail interaction in the structure of hexahistidine-tagged
Thermoplasma acidophilum citrate synthase. Acta Crystallographica Section F: Structural Biology Communications 71.10 (2015): 12921299.
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(Karpusas et al., 1990; Remington, 1992), remains broadly consistent with subsequent
experimental findings. Computation-based models for the proton transfers involved in
carbon–carbon bond formation (Donini et al., 2000; Mulholland et al., 2000; Yang &
Drueckhammer, 2003; van der Kamp et al., 2008, 2010) have not reached consensus
(Aleksandrov et al., 2014).
CS from the thermophilic, acidophilic euryarchaeon Thermoplasma acidophilum
(TpCS; Danson et al., 1985) has several advantages for mechanistic studies, among them
an endogenous fluorophore that reports directly on enzyme chemistry (Kurz et al., 2000,
2005). TpCS Trp348 fluorescence is strongly quenched by OAA binding nearby (Kurz et al.,
2005). The subsequent addition of either carboxymethyl-CoA (CMCoA) or carboxymethyldethiaCoA (CMX), potent CS inhibitors that resemble the deprotonated AcCoA species
produced during the condensation reaction, forms a ‘closed’ ternary complex (Bayer et
al., 1981; Karpusas et al., 1990; Kurz et al., 1992) but has little effect on TpCS fluorescence
(Kurz et al., 2005). Quenching is, however, alleviated by the subsequent addition of
dethiaacetyl-CoA (AcMX), an AcCoA analog that contains a methylene instead of sulfur
(Martin et al., 1994; Kurz et al., 1997, 2005). The fluorescence increase is owing to
destruction of the Trp348 quencher, the polarized OAA carbonyl, by its conversion to an
sp3 carbon in the nonhydrolyzable CitCoA analogue dethiacitryl-CoA (CitMX; Kurz et al.,
2009). Reversible, stoichiometric formation of a nonhydrolyzable binary TpCS–CitMX
complex was detected by equilibrium fluorescence analysis, pre-steady-state kinetics and
a crystal structure (PDB entry 2r9e; C. Lehmann, L. C. Kurz & T. E. Ellenberger, unpublished
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work). Since the TpCS protein conformation is almost the same in the ternary TpCS–OAA–
CMCoA complex (PDB entry 2r26; C. Lehmann, L. C. Kurz & T. E. Ellenberger, unpublished
work), the active site arrangement is likely to represent the configuration used for the
condensation reaction, not hydrolysis. This study addresses two barriers to the further
study of conformational changes in TpCS. Firstly, an unliganded structure of TpCS has
been reported (Russell et al., 1994) but the coordinates have not been deposited. This
hampers the analysis of protein motions accompanying the formation of the TpCS–OAA
(PDB entry 2ifc; C. Lehmann, L. C. Kurz & T. E. Ellenberger, unpublished work) and TpCS–
OAA–CMCoA complexes. Secondly, TpCS purification involves a dye-linked affinity column
(Sutherland et al., 1991) that may displace (acyl-) CoA ligands (Weitzman & Ridley, 1983)
and irreversibly binds at least one mutant protein (Constantine, 2009). Here, we report
the purification, characterization and crystal structure of TpCS fused to a C-terminal
hexahistidine affinity tag (TpCSH6). While the affinity tag has only minor effects on
enzyme function in solution, it promotes the formation of a crystal with a His tag bound
to an adjacent active site. Liganded and ‘empty’ partner subunits adopt essentially the
same ‘open’ conformation.
2.2

Materials and Methods

DNA manipulations
Oligodeoxynucleotides (ODNs) were from IDT (Coralville, IA). DNA-modifying enzymes
were from New England Biolabs (Beverly, MA). A Vent DNA polymerase PCR product,
obtained with ODN primers 1306 and 1307 (Table 1) and plasmid pRec7-ArCS as template,
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added flanking NdeI and XhoI sites to the gltA open reading frame and deleted the native
stop codon. Ligation into the corresponding sites of plasmid pET24a furnished TpCSH6
expression plasmid pJK438, which adds a 15-residue peptide VDKLA AALEH HHHHH
(residues 385-399) to the native C-terminus of TpCS. A QuikChange mutagenesis kit
(Agilent, La Jolla, CA), pJK438, ODN 2066 50-GCTGCAaGGCGGTGCAGCTGAGG), and
ODN 2067 50-ACCGCCtTGCAGCGGACCCTTG) were used to construct the TpCSH6- H222Q
expression plasmid pJK511. Bidirectional Sanger sequencing of the coding region was
used to confirm that both plasmids contained the expected DNA sequences.
Macromolecule production
Escherichia coli C41 (DE3) cells transformed with either pJK438 or pJK511 (cloning
procedures are given in the Supporting Information) were propagated in LB medium
supplemented with 50 mg l1 kanamycin. Production cultures (1 L) were grown at 310 K to
an optical density at 600 nm of 0.6, at which point isopropyl -d-1-thiogalactopyranoside
(IPTG; Gold Biotechnology, St Louis, Missouri, USA) was added (0.4 mM final
concentration) to induce protein production. After a further 16 h, the cells were harvested
by centrifugation (8000g for 15 min at 277 K), resuspended in 8 ml buffer H (20 mM Tris–
HCl pH 8.0, 100 mM KCl) per gram of wet cell weight and disrupted by sonication.
Streptomycin was added to a final concentration of 1% (w/v) from a 10%stock and solids
were removed by centrifugation (30 000g for 10 min at 277 K). Column-chromatography
steps were performed at 295 K under gravity flow. A Ni2+-loaded iminodiacetic acid
Sepharose column (Sigma–Aldrich, St Louis, Missouri, USA; 2.5 3.5 cm, 14 ml column
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volume) was washed with buffer H (140 ml) and the cleared cell lysate was applied. The
column was washed with buffer H containing 20 mM imidazole (42 ml) and was developed
with buffer H containing 250 mM imidazole (100 ml). Protein-containing fractions were
pooled and concentrated to >5 mg ml1 by ultrafiltration using an Amicon Ultra-15
centrifugal filter unit (EMD Millipore, Billerica, Massachusetts, USA). Solid ammonium
sulfate was added to 85% saturation at 277 K over 30 min. After stirring for a further 30
min at 277 K, aliquots were taken and stored as a slurry at 277 K. For crystal production,
an aliquot was dissolved in a minimal volume of TE (20 mM Tris–HCl pH 8.0, 1 mM EDTA)
and applied onto a Sephadex 200 gel-filtration column (2.5 x 8 cm; Pharmacia, Uppsala,
Sweden) that was developed in TE. Protein containing fractions were collected, pooled
and concentrated to 5 mg ml1. Exchanged samples were kept at 277 K and used within
12 h. Proteins were quantitated by the method of Bradford using bovine serum albumin
as a standard (Bradford, 1976). Gel-filtration analysis was used to determine molecular
sizes as described by Mullins et al. (2013). Macromolecule- production information is
summarized in Table 1. Enzyme activities were determined using a continuous assay that
detects CoA release by monitoring the cleavage of 5,50-dithiobis(2-nitrobenzoic acid)
(DTNB) at 412 nm (Δϵ = 14.1 mM-1 cm-1; Srere et al., 1963; Srere, 1969; Riddles et al.,
1979). One unit (U) is defined as the amount of enzyme required to produce 1 mmol of
product per minute.
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Table 2.1

† The restriction sites in ODNs 1306 (forward, NdeI) and 1309 (reverse, XhoI) are
underlined. Stop codon 385 is replaced by the vector-encoded tag sequence. ‡ The
recombinant protein lacks an N-terminal Met. The 15-residue His6 tag appended to the
C-terminus of the native sequence is underlined.
Enzyme kinetics and inhibition analysis
Enzyme activities at 298 K were recorded on a Cary 100 spectrophotometer
(Varian) equipped with a Peltier temperature controller. Nonlinear least-squares fitting
was performed using using gnuplot (version 4.4). Enzyme initial velocities were
determined in a final volume of 0.7 mL that contained 50 mM 4(2-hydroxyethyl)-1piperazinepropanesulfonic acid (EPPS), pH 8.0, 0.1 mM EDTA, 0.3 mM DTNB, either 15 M
or 0.4 mM OAA, variable amounts of the other substrate, and either TpCSH6 (0.6 g) or
TpCSH6-H222Q (20 g). Kinetic constants were obtained by fitting initial velocity data to
the Michaelis-Menten equation. AcMX, synthesized by Hong Jiang as described (Francois
et al., 2006), was used to prepare the TpCS CitMX complex (PDB entry 2r9e) and assessed
as a TpCSH6 inhibitor. Initial velocities were measured in a final volume of 0.7 mL that
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contained 50 mM potassium phosphate, pH 8.0, 100 mM KCl, 0.4 mM OAA, 0.3 mM DTNB,
varied AcCoA, and several fixed concentrations of AcMX. Reactions were initiated by the
addition of TpCSH6 (0.6 mg). Lineweaver-Burk plots showed a competitive inhibition
pattern. All initial velocity data were globally fit to a Michaelis-Menten equation in which
KMapp = KM(1 + [AcMX]=Ki).
Ligand affinity measurements
Fluorescence emission spectra (excitation 295 nm) were recorded using a
Fluoromax-3 (Horiba) spectrofluorimeter at 298 K. Emission spectra were corrected for
dilution and, using a control titration of N-acetyl-l-tryptophanamide, the inner filter effect
due to OAA. Titration data monitoring changes in the fluorescence emission intensity at
315 nm (F) were plotted by normalizing F by the emission intensity measured in the
absence of titrant (Fo). Protein-ligand affinities were determined by fits to Eqn. 1 (for
Kd=[E] > 5, where [E] is the subunit concentration of the enzyme) or Eqn. 2, which
accounts for changes in [L] (either [OAA] or [AcMX]) due to ligand depletion.
𝐹𝐹 = 𝐹𝐹0 +
𝐹𝐹 = 𝐹𝐹0 +

𝛥𝛥𝛥𝛥[𝐿𝐿]

(1)

𝛥𝛥𝛥𝛥

(2)

𝐾𝐾𝑑𝑑 +[𝐿𝐿]
2[𝐸𝐸]

([𝐿𝐿] + 𝐾𝐾𝑑𝑑 + [𝐸𝐸] + �[𝐿𝐿] + 𝐾𝐾𝑑𝑑 + [𝐸𝐸]2 + 4[𝐿𝐿][𝐸𝐸]

Crystallization
Sparse-matrix crystallization screens performed using the Wizard I and II kits
(Emerald Bio) yielded two hits after 27 d: condition I-1 [20% PEG 8000, 0.1 M 2(cyclohexylamino)-ethanesulfonate (CHES) pH 9.5] and condition I-26 (Table 2), each
supplemented with 1 mM OAA. Crystals with a similar appearance were obtained in the
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same buffer after 10 d in drops (2–4 ml prior to mixing with an equal volume of reservoir
solution) containing 8–10% PEG 4000 and 5 mg ml1 TpCSH6 with or without OAA. Single
crystals were loaded into nylon loops (Teng, 1990), transferred to reservoir solution
supplemented with 15%(w/v) sorbitol for 10 min, rapidly immersed in liquid nitrogen and
maintained at or below 100 K until data collection was complete.
Table 2.2 Crystallization

Data collection and processing
All screened crystals diffracted X-rays weakly and with high mosaicity. The best
diffraction patterns were obtained from a TpCSH6 crystal that adhered to the side of the
mounting loop. The unusual sample geometry hampered the collection of a complete Xray diffraction data set, which was recorded in three passes using different regions of the
crystal. Diffraction data from one-pass, two-pass or three-pass sets were processed using
the HKL-2000 suite (Otwinowski & Minor, 1997). Single-pass data sets had similar
statistics (not shown), including individual Rsym values that were comparable to the
Rmerge value for the full (three-pass) data set (Table 3).
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Table 2.3
Data collection and processing.
Values in parentheses are for the outer shell.

Structure solution and refinement
PHENIX and Coot were used for structure solution and refinement (Emsley et al.,
2010; Adams et al., 2010). Molecular replacement was performed with Phaser (McCoy et
al., 2007) using subunit A from PDB entry 2ifc, with all buffer components and side-chain
atoms beyond C removed, as the search model. The sole solution contained four subunit
in the asymmetric unit (residues 4–383; the TpCS numbering excludes Met0). One round
of phenix.autobuild (with default settings) was performed to repair side chains. Iterative
cycles of model improvement and refinement, using noncrystallographic symmetry (NCS)
restraints and a hybrid TLS–isotropic ADP model, were performed until Rfree appeared to
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converge. The C-terminal appendage (residues Val386– His399) was added using Coot.
NCS restraints were dropped in the final refinement cycles. MolProbity was used to check
the protein geometry (Chen et al., 2010). Pairwise alignments and root-mean-square
deviation (r.m.s.d.) computations were performed using one cycle of the align algorithm
implemented in PyMOL (v.1.7.4.2; DeLano, 2002). Domain motions were computed using
the DynDom server (v.1.5; default settings; Hayward & Berendsen, 1998; Hayward & Lee,
2002). Protein images were based on PyMOL or LIGPLOT (Wallace et al., 1995) output.

2.3

Results and Discussion

Comparison of TpCSH6 and TpCS
TpCSH6 was overexpressed in E. coli, purified and found to be a dimer (Figure 2.1)
with a specific activity of 52 U mg-1 at 328 K and 22 U mg-1 at 298 K (8 s-1, assuming one
active site per subunit). Substrate-saturation analyses (Figure 2.2) yielded Michaelis
constant (KM) values of 3.0 mM for AcCoA and 5.2 mM for OAA. AcMX was a competitive
inhibitor versus AcCoA (Ki = 20 μM; Figure 2.3). These results, and the relatively high
batch-to-batch variability in specific activity, are comparable to those for TpCS
(Sutherland et al., 1991; Kurz et al., 2000).
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Figure 2.1. Gel filtration analysis of TpCSH6 (black trace) and TpCSH6-H222Q (blue trace)
at 277 K in 50 mM Tris HCl, pH 8.0, and 100 mM KCl. Molecular size analysis was
performed as described previously (Mullins et al., 2013). The arrows indicate the elution
volumes for Blue Dextran (void) and acetone (incl) standards. Each elution profile reaches
a maximum at 73.6 mL (81 kDa), as expected for a dimer of 43 kDa subunits.

Figure 2.2. Determination of steady-state kinetic parameters for TpCSH6. Specific
activities were measured using the DTNB assay at 298 K for AcCoA at 0.4 mM OAA (filled
circles) or OAA at 15 M AcCoA (open circles). Solid lines depict fits to to the MichaelisMenten equation: AcCoA, KM = 3.0±0.4 μM and Vmax = 12.7±0.5 U/mg; OAA, KM = 5.2±0.4
μM and Vmax = 10.8±0.2 U/mg.
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Figure 2.3. Determination of a competitive inhibition constant (Ki) for AcMX. Global fit
parameters were: KM = 3.3±0.2 μM, Ki = 19.9±2.1 μM, and Vmax = 17.4±0.3 U/mg.
[Phosphate weakly inhibits TpCS (Kurz et al., 2009).] The solid lines represent curves
computed using global fit parameters at 0 (black open circles), 10 μM (blue filled
diamonds), 25 μM (purple open diamonds), and 50 μM (red filled circles) AcMX.
Purified TpCSH6-H222Q, a mutant located in the AcCoA binding site, had a specific
activity of 0.01 U mg1 at 298 K or 0.05% of that of the wild type. Since the mutant enzyme
was isolated from a gltA+ E. coli strain, the observed activity could be associated with a
contaminating host enzyme. However, the ‘activity’ did not increase as AcCoA was varied
from 30 to 400 mM (at 0.4 mM OAA; data not shown), which suggests that host CS is not
present. We conclude that TpCSH6-H222Q is nearly or completely devoid of enzymatic
activity, and that the protein-isolation method can be used to study even very low-activity
mutants produced in common protein-production strains.
Fluorescence titrations were used to measure OAA dissociation constants (Kd) of
0.76 and 19 µM for TpCSH6 and TpCSH6-H222Q, respectively (Figure 2.4). Saturating OAA
quenched the fluorescence of both forms to about half of the initial level, which differs
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from a report that TpCS-H222Q fluorescence is quenched to a relatively greater extent
(Kurz et al., 2009). As observed for TpCS, the addition of AcMX to the TpCSH6–OAA
complex results in a 124% increase in fluorescence (Kd = 1.5 µM) owing to the formation
of CitMX (Figure 2.5). The Kd values determined for untagged TpCS(-H222Q) at 293 K were
comparable: 1.3, 33 and 1.47 µM, respectively (Kurz et al., 2005, 2009).

Figure 2.4. OAA affinities determined by fluorescence titration. OAA titrations were
performed by adding aliquots to a constantly stirred 2 mL volume that contained 50 mM
EPPS, pH 8.0, 0.1 mM EDTA, and either TpCSH6 or TpCSH6-H222Q. Spectra were recorded
3 min after each ligand addition. The OAA-dependent quenching of TpCSH6 (0.2 μM, filled
circles) or TpCSH6-H222Q (1 μM, open circles) were analyzed by fits to Eqn. 2 and Eqn. 1,
respectively. Solid lines depict fits for TpCSH6 (black curve) and TpCSH6 (purple curve),
divided by Fo: Kd = 0.76±0.06 and 19±1 μM and maximal (e.g., [OAA] → ∞ 1) -ΔF=Fo =
0.541 and 0.603, respectively. Note that [OAA] in the TpCSH6-H222Q titration was 10-fold
higher than indicated on the abscissa.
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Figure 2.5. AcMX affinity for TpCSH6OAA determined by fluorescence titration.
Experimental conditions were the same as described in Fig. 2.4, except that 0.2 mM OAA
was also present. The AcMX-dependent increase in F is due to conversion of the
fluorescence quencher OAA to CitMX. The solid line depicts a fit of the titration data to
Eqn. 2, divided by Fo, with Kd = 1.5±0.1 μM and maximal F=Fo = 1.24± 0.01.
Crystal structure of TpCSH6
Initial attempts to crystallize TpCSH6 focused on HEPES/sodium acetate (pH 7.5–
8.5) conditions, identified by robotic screening that yielded crystals of TpCS bound to one
or more ligands (Christopher Lehmann, unpublished observations). No suitable TpCSH6
crystals were obtained in attempts to manually reproduce these conditions. A sparsematrix screen identified high-pH conditions that yielded large crystals (Table 2). The
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inclusion of OAA in the crystallization solution (Table 2) had no obvious effect on crystal
morphology. A cryocooled crystal (0.1 0.1 1.0 mm) grown in the presence of OAA was
selected for X-ray data collection. Several attempts to crystallize TpCSH6-H222Q under
similar conditions yielded only microcrystals.
The three-pass data set was selected for further analysis because the
completeness and electron-density maps (Figure 2.6) were superior to those computed
using the one-pass or two-pass data sets (not shown). Molecular replacement and
refinement proceeded smoothly, furnishing a final model with acceptable statistics (Table
4). Like TpCS (Russell et al., 1994), TpCSH6 crystallized in space group P21 with two dimers
in the asymmetric unit, albeit with rather different unit-cell parameters (Table 3). TpCSH6
had almost the same monomer topology as unliganded TpCS (Figure 2.7). Pairwise
alignments of TpCS (coordinates provided by Linda C. Kurz) and TpCSH6 subunits gave
r.m.s.d. values of 0.40–0.59 A ° (C only) and 1.15– 1.25 A ° (all protein atoms). Pairwise
alignments of the TpCSH6 subunits (residues 5–383) gave r.m.s.d. values of 0.26–0.42 A °
(C only) and 0.68–0.91 A ° (all protein atoms). TpCSH6 subunit C and the CD dimer were
selected to represent the open conformation in all subsequent comparisons.
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Table 2.4
Structure refinement.
Values in parentheses are for the outer shell.
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Figure 2.6. Representative map-model agreement. Electron density maps near Trp348
(subunit C) are shown: A-weighted 2mFo–DFc (grey mesh, 1:5) and mFo–DFc (green and
red mesh, 3). The Trp348 rotamer, which is essentially the same as in liganded TpCS
structures, is flipped (-171 rotation) relative to the rotamer observed in the structure of
TpCS (Russell et al., 1994).
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Figure 2.7. Primary sequence, secondary structure, and domain motions in TpCS(H6). The
C-terminal appendage of TpCSH6 is indicated with a grey background. In keeping with
prior practice, the initiator codon is assigned the number zero. The elements of secondary
structure are given the same designations as in TpCS, apart from a short helix (16) and Cterminal appendage helix (U) that were not present in the apo TpCS structure. The colored
symbols correspond to mobile domains (underlined) and hinge residues (carets) identified
by DynDom comparisons of TpCSH6 with one ligand-bound TpCS subunit.
As expected for a relatively long exposure to synchrotron X-rays, alterations
consistent with mild X-ray damage were observed, including Asp/Glu decarboxylation and
loss of methanethiol in surface-accessible residues (Garman, 2010) such as Asp301B and
Met241C. Two well ordered bicarbonate ligands were included in the final model. This
was justified by the high pH of the mother liquor and the presence of OAA, which can
spontaneously decarboxylate. These anions ‘cap’ the N-terminal (positive) end of the long
Q helix in subunits B and C. The side chain of the single Ramachandran outlier, Lys237C,
makes a well defined salt bridge with the side chain of Glu158D from a neighboring
asymmetric unit. Positive difference electron density was observed early in refinement at
two locations: a helix near the CD dimer interface and the nearby subunit D active site.
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These features were linked to form the C-terminus of subunit A. Dimers AB and CD are
bridged at the center of the asymmetric unit by two C-terminal appendages extending
from subunits A and D (Figure 2.8). The C-terminal native sequence of subunit A wraps
halfway around the large domain of the B subunit. The C-terminal tag sequence continues
past helix T towards the CD interface, making a perpendicular turn to form the extra helix
(U). A second sharp turn near residue His222D directs the tag sequence into the active
site of subunit D, ending with a bidentate salt bridge formed between the C-terminal
carboxylate of the tag residue His399A and the rg271D guanidinium. A similar interaction
is formed between the C-terminus of subunit D and the active site of subunit A. NCS
comparisons indicate the backbones diverge after Arg383, with helix U displaced along its
axis about 2 A ° farther from the CD dimer than the AB dimer. No electron density
consistent with the C-terminal appendage of subunits B or C was observed. Small affinitytag appendages occasionally form crystal-packing contacts (Carson et al., 2007). The
TpCSH6 His6 tag is one of a small number of ordered affinity tags that bind to an enzyme
active site (Taylor et al., 2005; McDonald et al., 2007; Singh et al., 2011; Wojtkowiak et
al., 2012).
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Figure 2.8. Crystal-packing diagram for TpCSH6. Subunits A–D in the monoclinic
asymmetric unit are colored green, blue, purple and gold, respectively. Residues in the Cterminal appendage, shown as spheres in subunits A and D (indicated by arrows), occupy
the active sites of subunits D and A, respectively. Left, ribbon rendering shows that the Ctermini bind deep within the AB and CD dimers. In this orientation, the twofold screw axis
(b axis) runs along the Cartesian x axis. The C-terminal appendage contacts active-site
residues involved in binding both OAA and AcCoA (Figure 2.9). This was unexpected, as the
hexahistidine sequence has no resemblance to either substrate. The C-terminal residue
His399 makes a side-chain contact with His222, a residue that provides a hydrogen bond
(involving N1) that polarizes the AcCoA enolate, and the terminal carboxylate contacts
both His262 and Arg271, which bind carbonyl and -carboxylate O atoms in OAA. Since the
His399–His222 contact involves two N1 atoms, one residue adopts a tautomer (N1–H),
which is uncommon at high pH (Sudmeier et al., 2003; Li & Hong, 2011) but is employed by
some active-site residues (Day et al., 2003). The local hydrogen-bonding context and the
proposed role for the neutral tautomer in the condensation reaction (summarized in van
der Kamp et al., 2007) suggest that His222 adopts the tautomer even in the absence of
acetyl-CoA. Similarly, flipping the His398 imidazole would worsen the hydrogen-bonding
context and introduce clashes, which suggests it may also adopt a tautomer stabilized by
Ala191 NH (Fig. 2). His397 N"2 forms a hydrogen bond to one carboxylate O atom in the
critical active-site base Asp317, which is not directly contacted by either substrate (Figure
2.10). Similar contacts are observed between Asp317 equivalents and strong inhibitors
such as CMCoA and CMX (Usher et al., 1994; Francois et al., 2006)
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Figure 2.9. Active site of TpCSH6 subunit A bound to the C-terminus of subunit D (blue
bonds). All illustrated residues also contact OAA (His262 and Arg271) or AcCoA (the
remainder). His222 and Asp317 are responsible for deprotonating the AcCoA acetyl
group, stabilizing the resulting enolate/carbanion and promoting the condensation
reaction that produces CitCoA. An intra-residue hydrogen bond that stabilizes the neutral
tautomer of His222 is shown in black. A similar analysis of the TpCS active site bound to
the CitCoA analogue CitMX (Figure 2.10) shows that many of the same residues are
involved in substrate contacts. All polar contacts presumed to result in hydrogen-bonding
interactions are shown, with distances in Å
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Figure 2.10. Active site of TpCS CitMX complex (PDB entry 2r9e) showing selected polar
protein-ligand interactions. CitMX differs from CitCoA by an atomic substitution (S→CH2)
indicated with an arrow. TpCS forms CitMX by condensing AcMX and OAA, forming the
bond denoted in magenta. Residues with names shown in red are also involved in binding
the C-terminus of TpCSH6 subunit A or D (Fig. 2.2). The prime denotes a residue from the
partner subunit in the TpCS dimer; note that the C-terminus only engages residues from
one subunit. Polar contacts with the CoA region by Leu257, Gly259, Phe260, Asn315, and
Arg 361 are omitted.
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Bisubstrate analogues can be potent and selective enzyme inhibitors (Collins &
Stark, 1971; Radzicka & Wolfenden, 1995; Schramm, 2013). Clinically useful examples
include finasteride, which is converted to a tight-binding bisubstrate analogue by its
target enzyme (Bull et al., 1996). The stoichiometric ligand CitMX is a bisubstrate analogue
inhibitor of CS that (like finasteride) is formed by its target enzyme (Kurz et al., 2009).
Reversible formation of CitMX by TpCS might therefore contribute to inhibition by AcMX
(Martin et al., 1994), although its potency could be sapped by harnessing ‘binding energy’
to drive the condensation reaction (Page & Jencks, 1971). CS is a highly specific enzyme
that possesses a highly basic active site that binds two polyanionic substrates. All known
potent CS inhibitors are unpromising starting points for drug design: they closely
resemble the substrates and would encounter substantial barriers to cellular uptake. In
contrast, imidazoles should be mostly uncharged at the basic pH, which may allow crystal
growth by alleviating electrostatic repulsion between the active site and the His6 tail. This
near-neutral peptide ligand could represent a useful alternative starting point for the
identification of CS inhibitors.
To test the hypothesis that the CS active site has detectable affinity for a poly-His
ligand, TpCSH6 was incubated with a dansyl-His3 synthetic peptide (Genscript,
Piscataway, New Jersey, USA). Fluorescence changes consistent with Fӧrster resonance
energy transfer between the tripeptide and TpCSH6, presumably the nearby Trp115, were
not observed (data not shown). Gel-filtration studies indicated that unliganded TpCS,
TpCSH6 and TpCSH6-H222Q were each exclusively dimeric in solution (Fig. 2.1). Deletion
of a hydrogen bond between the active-site residue His222 and the appendage residue
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His399 appears to thwart TpCSH6-H222Q crystal growth. This sensitivity suggests a weak
peptide–protein interaction that is stabilized by cooperative crystal-packing interactions.
TpCS conformational changes associated with ligand binding
Substrate exclusion by the C-terminal appendage could explain why the crystal
morphology was unaffected by the addition of saturating OAA but only half of the active
sites are occupied by peptide in the crystal (ordered solvent is observed in the other two
active sites). The striking finding that all four subunits adopt open conformations suggests
that the TpCS dimer cannot close just one active site. Previous CS crystal structures have
a high degree of NCS and contain the same ligand(s) in both active sites. Since to our
knowledge there is no evidence for cooperative binding of OAA by any CS, it is possible
that the open conformation is trapped within the crystalline lattice.
The preferred rotamer at Trp348, or the residue occupying this position, has been
reported to change upon ligand binding and concomitant enzyme closure (Kurz et al.,
2005). The TpCS structure possesses m95 (Trp348A) and p90 (Trp348B) rotamers (Russell
et al., 1994), each modeled with a C—C—C bond-angle outlier ( > 5.5). In TpCSH6 and the
three deposited TpCS structures, however, only m0 rotamers were observed in
unambiguous electron density in all subunits (Figure 2.6). It is possible that binding of the
C-terminal appendage to the TpCSH6 active site, which does not cause domain closure,
triggers a Trp348 ring flip. A simpler model, however, is that the Trp348 indole does not
ring flip, consistent with the fluorescence properties, which indicate a rigidly immobilizing
protein environment (Kurz et al., 2005).
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Using the new TpCSH6 structure as a reference, we examined the series of protein
conformational changes associated with ligand binding, domain closure and the
condensation reaction (Figure 2.7). As anticipated, the binding of OAA is associated with
a conspicuous closure of the active site: a rotation of the small domain relative to the
large domains that form the major dimer interface (Figure 2.11a). Each of the domains is
relatively monolithic, with pairwise r.m.s.d. values of <1 Å, and similar sets of hinge
residues are involved. This motion is similar to the larger (19.4) rotation observed in the
canonical vertebrate CS open/closed pair (PDB entries 1cts/1csh; Remington et al., 1982;
Usher et al., 1994; Hayward & Berendsen, 1998). Domain closure increases when a CoA
analogue is also present (Figures 2.11b and 2.11c). As noted above, the TpCS–OAA–
CMCoA and TpCS–CitMX complexes adopt similar protein structures, suggesting that they
both represent the configuration associated with the condensation reaction.
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Figure 2.11. Domain motions in TpCS(H6). Each panel shows the open TpCSH6 structure
superimposed on a closed TpCS structure in pairwise DynDom analyses. The static
portion, mainly the large domains that form the majority of the dimer interface, is shown
as a surface rendering. The mobile domain extends from the surface and is shown in
cartoon rendering, with the TpCSH6 mobile region colored red and the closed structure
colored grey. Hinging residues in each TpCSH6 domain are colored yellow. Residues
involved in each pairwise comparison are shown in Figure 2.7. The rotation axis is shown
as a black bar; closure results in clockwise rotations about this axis. (a) Comparison with
the TpCS–OAA complex (PDB entry 2ifc subunit A) shows 52% closure and a 8.9 rotation
(translation of 0.1 Å). Mobile domain: 99 residues, r.m.s.d. 0.41 Å . Static domain: 277
residues, r.m.s.d. 0.52 Å. (b) Comparison with the TpCS–OAA– CMCoA complex (PDB
entry 2r26 subunit A) shows 86% closure and a 10.6 rotation (translation of 0.4 Å). Mobile
domain: 115 residues, r.m.s.d. 0.68 Å. Static domain: 258 residues, r.m.s.d. 0.69 Å. CMCoA
is a tight-binding analogue of the deprotonated AcCoA formed during the condensation
reaction. (c) Comparison with the TpCS–CitMX complex (PDB entry 2r9e subunit B) shows
82% closure and a 10.3 rotation (translation 0.4 Å). Mobile domain: 123 residues, r.m.s.d.
0.83 Å. Static domain: 252 residues, r.m.s.d. 0.7 Å. CitMX is formed from AcMX and OAA,
presumably within the crystal.
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2.4

Conclusions

TpCSH6 is an active enzyme useful for solution studies of the CS mechanism. It
unexpectedly produced a new crystal form that appears to prevent ligand
cocrystallization. The serendipitous peptide ligand, with a total charge of near zero, binds
both parts of the CS active site. Using this complex as an inspiration, it may be possible to
identify an alternative drug scaffold to target this key step in primary metabolism.
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CHAPTER 3. FUNCTIONAL DISSECTION OF THE BIPARTITE ACTIVE SITE OF THE CLASS I
COENZYME A (COA) TRANSFERASE SUCCINYL-COA: ACETATE COA-TRANSFERASE

3.1

Introduction

Substrate-dependent ordering of flexible active site loops can transmute substrate
(ligand) binding affinity into faster enzymatic reactions (Jencks, 1975; Malabanan et al.,
2010). When loop motions move critical functional groups, it is unclear if protein motions
bias the enzyme-substrate complex conformational ensemble towards a reactive
configuration or simply assemble the catalytic machinery. Enzymes with large substrates,
like the coenzyme A (CoA) based molecules used throughout metabolism, have ample
opportunity to exploit substrate affinity to promote catalysis.
A classic example of this phenomenon is provided by the CoA-transferases, which
activate metabolism of diverse carboxylate substrates by introducing the versatile and
reactive CoA thioester (Moore and Jencks, 1982a; Amyes and Richard, 1992; Yang and
Drueckhammer, 2001), often at the expense of acetyl-CoA (AcCoA). Acetobacter aceti
strain 1023 and other acetic acid bacteria use succinyl-CoA: acetate CoA-transferase
(AarC) in a variant citric acid cycle that is required for a robust acetic acid resistance (aar)
phenotype (Mullins et al., 2008). Strong selection for key roles in acetic acid resistance
and central metabolism appear to have optimized the structural and functional properties
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of AarC, making it an excellent representative of the class I CoA-transferase superfamily.
Class I acyl-CoA: carboxylate CoA-transferases produce reactive acylglutamyl anhydride
intermediates that acylate CoA, forming either an acyl-CoA product and a free enzyme or
a protein glutamyl-CoA thioester and a carboxylate product. Jencks proposed that active
site closure, which immobilizes the acyl thioester, potentiates catalysis (White and Jencks,
1976). Efficient catalysis requires an intact CoA, consistent with long-range mechanical
coupling of remote “binding” regions to the site of chemistry (Fierke and Jencks, 1986;
Whitty et al., 1995).
The Jencks hypothesis was substantiated by a set of AarC crystal structures,
including a trapped acetylglutamyl anhydride intermediate in which the CoA sulfur atom
lies equidistant from two (external and internal) carbonyl carbon atoms (Mullins and
Kappock, 2012). Competing thiolysis reactions (Figure 3.1) produce distinct tetrahedral
oxyanion intermediates ~3 Å apart. The external oxyanion is stabilized by hydrogen bonds
from CoA and Gly388 amides, whereas the internal oxyanion is stabilized by a hydrogen
bond from the Asn347 carboxamide. While components of the external oxyanion hole are
strictly conserved throughout the class I CoA-transferase superfamily, residues forming
the internal oxyanion hole are supplied by different parts of the protein and are
conserved within two large subsets of the superfamily.
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Figure 3.1. Class I CoA-transferase mediated acyl transfers involve two spatially distinct
oxyanion holes. The reversible conversion of acyl-CoA substrate to the carboxylate
product is shown, a half-reaction that converts free enzyme into a glutamyl-CoA thioester
adduct. The other half-reaction reverses this reaction sequence. Inset, overlay of the
"open" AarC•CoA complex (PDB entry 4eu7) with the "closed" AarC-E294A•1a complex
(PDB entry 4euc) indicates that constriction of the active site around an acyl-CoA
substrate causes extreme C/O overlap at an approach angle close to the ideal for
nucleophilic attack on an unsaturated carbon (the Bürgi-Dunitz angle, 107°). The arrow
indicates the position of the sulfur-for-methylene substitution in the AcCoA analogue 1a,
which contains a nonhydrolyzable ketone.
AarC crystal structures revealed that substrate binding provides the last piece of
the external oxyanion hole, a hydrogen bond supplied by the CoA N4P hydrogen (Figure
3.1), and have begun to delineate steps in active site closure, a multi-step process that
constriction of the acyl-CoA substrate (Mullins and Kappock, 2012). Properly positioning
Val270, a residue at the tip of one of two loops that move the most during active site
closure, appears to be particularly important: its side chain is proposed to desolvate and
constrain the thioester while its amino group is proposed to supply a hydrogen bond
donor that stabilizes the CoA thiolate leaving group produced by anhydride formation.
The amide-thiolate interaction would both stabilize the nucleophile that attacks the
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anhydride and help maintain the 270s loop in a closed state during reactions involving the
anhydride adduct. A crystal structure of an inactive mutant, AarC-E294A, bound to the
nonhydrolyzable AcCoA analogue dethiaacetyl-CoA (Figure 3.2; 1a), suggests that active
site closure crushes the acyl-CoA thioester into the Glu294 nucleophile, enforcing a nearideal Bürgi-Dunitz angle (Bürgi et al., 1973) and confining the thioester oxygen atom in
the external oxyanion hole (Mullins and Kappock, 2012). In contrast, ligand binding seems
to have little effect on the internal oxyanion hole, although the subsequent active site
closure process may alter its dielectric environment.

Figure 3.2. Compounds used in this work.
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In this study, we used crystal structures of active AarC forms to study enzyme
closure and probe the assembly of both oxyanion holes. Mutagenesis of the internal
oxyanion hole resulted in diminished but not completely lost enzyme activity (Mullins and
Kappock, 2012). Since the external oxyanion hole is composed of backbone and CoA
atoms, analogues incapable of undergoing complete enzymatic conversion were used to
examine the assembly of a closed enzyme-ligand complex. Compound 1a was
unexpectedly degraded by microbial contamination, yielding a crystal containing an
acetylglutamyl anhydride adduct and a CoA analogue (modeled as 2a). A complex of wildtype AarC and authentic 2a, which deletes a hydrogen bond between the Glu294
carboxylate and the CoA thiol, showed complete closure of the active site. Since complete
closure has not been observed in complexes of wild-type AarC and CoA, a specific polar
contact formed between the Glu294 nucleophile and CoA may enable AarC to discriminate
between acyl- CoA substrates and CoA. Selective prevention of complete active site
closure on CoA might allow CoA-transferases to avoid forming dead-end complexes with
ligands that cannot dissipate binding energy through enzyme catalysis.
3.2

Materials and Methods

Reagents and general analytical methods.
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO) or Fisher (Houston,
TX) unless otherwise noted. Dimethylformamide (DMF) was dried over 3A molecular
sieves under a N2 atmosphere. Oligodeoxynucleotides (ODNs) were obtained from
Integrated DNA Technologies (Coralville, IA) and used without further purification. Yeast
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acetyl-CoA synthetase (catalogue number A1765) and a rabbit pyruvate kinase/lactate
dehydrogenase mixture (catalogue P0294) were from Sigma. DNA modifying enzymes
were from New England Biolabs or Stratagene. Cells were disrupted at 4 °C by three
rounds of sonication (1 min on, 1 min cooling) using a Fisher Sonic Dismembrator 550.
The synthesis of 1a was described previously (Francois et al., 2006); no contaminating 1b
was detected (Figure 3.2). Absorbance measurements were recorded on a Cary Series UVVis spectrophotometer (Agilent; Santa Clara, CA) or Nanodrop 2000C (Thermo Scientific;
Milwaukee, WI), matrix assisted laser desorption ionization – time of flight mass
spectrometry (MALDI-TOF MS) was performed on a 4800 Plus MALDI TOF/TOF
(Farmington, MA). Daughter ion m/z values were computed assuming that adenine N1
can be protonated (Kapinos et al., 2011) or that the phosphates associate with either
protons or potassium ions.
DNA manipulations.
Plasmids pJK385, pJK513, and pJK524 encode AarC with a C-terminal hexahistidine tag
(AarCH6), AarCH6-E294A, and AarCH6-N347A, respectively (Mullins and Kappock, 2012).
For simplicity we will henceforth refer to AarCH6 proteins as AarC; the tagged and
untagged proteins produce isostructural orthorhombic crystals (PDB entries 4eu7 and
4eud, respectively). Plasmids pESC124, pESC106, and pET15b/bPanK encode E. coli CoaE,
CoaD, and PanK proteins, respectively, each with an N-terminal hexahistidine tag (Calder
et al., 1999; Strauss and Begley, 2002). Sequencing of pET15b/bPanK revealed a silent
mutation (T>C) in the His104 codon that removes an internal, endogenous NdeI site. E.
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coli

BL21(DE3)

ackA

oligodeoxynucleotides

was
2368

amplified

using

Pfu

TURBO

(5'-GCTGTCGCATATGTCGAGTAAGT)

polymerase
and

2369

and
(5'-

ATTAGCTCGAGTCAGGCAGTC). The resulting PCR product was cloned into the NdeI and
XhoI sites of pET28a to furnish plasmid pJK667, which is used to express AckA (acetate
kinase) with an N-terminal hexahistidine fusion (H6AckA). Double-stranded DNA
sequencing of all plasmids by the Purdue Genomics Core Low Throughput Laboratory
yielded the anticipated sequence. All plasmids described in this section are available
through Addgene (Herskovitch et al., 2012).
Production of CoA analogues 2a and 3a.
CoA biosynthesis enzymes were overexpressed in E. coli BL21(DE3) cells
transformed with pESC124, pESC106, or pET15b/bPanK and propagated on LB medium
supplemented with 100 mg/L ampicillin or 70 mg/L kanamycin. Production cultures were
grown with shaking at 220 rpm at 37 °C to an optical density at 600 nm of 0.6, at which
point isopropyl β-D-1-thiogalactopyranoside was added (0.4 mM final concentration).
After an additional 4 h at 37 °C, cells were harvested by slow centrifugation (5000g, 15
min) and stored at -80 °C.
H6AckA was produced in E. coli BL21(DE3) cells transformed with pJK667 and
propagated on LB medium supplemented with 100 mg/L ampicillin. Production cultures
of ZYM-5052 autoinduction medium (1 L) (Studier, 2005) were grown with shaking at 220
rpm at 37 °C for 18 h. Cells were harvested by slow centrifugation and stored at -80 °C.
The following protocol was used to isolate H6AckA, H6PanK, H6CoaD, or H6CoaE; all steps
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were performed at 4 °C. Cells were resuspended in 5 mL/g TM buffer (50 mM Tris-HCl pH
8.0) at 4 °C and disrupted by sonication (3 rounds of 1 min on and 1 min off, 20% intensity).
Debris was removed by fast centrifugation (30,000g, 30 min). The supernatant was
adjusted to 1% (w/v) streptomycin sulfate [10% (w/v) stock] and solids were removed by
fast centrifugation. The supernatant was applied under gravity flow to a Ni2+iminodiacetic acid Sepharose column (2.5 cm x 8 cm, ~5 mL) in TM buffer. After washing
with TM buffer containing 300 mM KCl and 40 mM imidazole (50 mL), bound proteins
were displaced using TM buffer containing 300 mM KCl and 500 mM imidazole (20 mL).
SDS-PAGE was used to identify fractions containing the relevant proteins. Fractions were
pooled, dialyzed 18 h against 50 mM Tris-HCl, pH 8.0, 100 mM KCl (1 L x 2 changes), and
either adjusted to 50% (v/v) glycerol and stored at -20 °C or flash-frozen (H6AckA) in liquid
N2 and stored at -80 °C. Specific activities were determined for H6AckA (Ferry, 2011) and
H6PanK (Francois et al., 2006).
N-propylpantothenamide and N-ethylpantothenamide were synthesized as
described previously (Strauss and Begley, 2002). Sodium pantothenate (2.0 g, 8.3 mmol)
was converted to the free acid using a Dowex 50W (H+ form) column (1.7 cm x 10 cm).
Pantothenic acid (1.7 g, 7.8 mmol) was dissolved in 10 mL dry DMF and either
propylamine or ethylamine (0.82 mL, 10 mmol) was added dropwise with continuous
stirring under a N2 atmosphere at 22 °C. Diphenylphosphoryl azide (2.2 mL, 10 mmol) was
then added dropwise and the reaction mixture was placed in an ice bath. After 10 min,
triethylamine (1.39 mL, 10 mmol) was added dropwise and the reaction mixture was
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stirred at 0 °C for 2 h, then 22 °C for 15 h. A portion (0.3 mL) of the reaction mixture above
was mixed with deionized water (1.2 mL), solids were removed by centrifugation (16000g,
10 min), and solvent was removed under reduced pressure at 60 °C. The resulting clear,
viscous oil was dissolved to give a ~0.1 M aqueous solution. A final volume of 5 mL
contained 50 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 5 mM ATP, 300 µg H6PanK (2.7 units),
300 µg H6CoaD, 1500 µg H6CoaE, and either 10 mM N-propylpantothenamide or Nethylpantothenamide. After 4 h at 37 °C, 0.5 mL formic acid (98%) was added and solids
were removed by centrifugation (16000g, 10 min). The quenched reaction mixture was
injected (5 mL) onto an Agilent 110 series HPLC equipped with a Luna 5 µm C18(2)
250x21.2 mm column equilibrated in 0.1% (v/v) trifluoroacetic acid (TFA), 2.0% methanol.
The column was developed in a gradient of 2% to 90% methanol in 0.1% TFA and large
peaks were collected, frozen, and lyophilized to dryness. The resulting solid, containing
2a or 3a (Figure 3.2), was resuspended in 5 mM HCl and concentrations were determined
by the absorbance at 260 nm assuming a molar extinction coefficient of 16.4 mM-1cm-1.
The

molecular

mass

and

purity

of

3'-phosphoadenosine

5'-(O-(N-propyl-R-

pantothenamide))pyrophosphate (2a) and 3'-phosphoadenosine 5'-(O-(N-ethyl-Rpantothenamide))pyrophosphate (3a) were assessed using LCMS (Agilent 1100 HPLC
G1946B).
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AarC production and characterization.
AarC and AarC mutants were expressed in C41(DE3) pREP4-groESL, purified, and
characterized by VisR and LCR activity assays as described previously (Mullins et al., 2008;
Mullins and Kappock, 2012). Sodium borohydride inactivation experiments were
performed as described previously (Mullins et al., 2008). Activities for AarC and other
enzymes are expressed in units, defined as 1 µmol product formed per min.
Crystal growth and X-ray data collection.
Crystals were grown at 22 ºC using the hanging-drop vapor-diffusion method by
modifying a published method (Mullins and Kappock, 2012). Reservoir solutions (0.5 mL)
contained 0.9 M sodium citrate, 0.1 M imidazole•HCl, pH 8.2, and 25 mM 2mercaptoethanol. Drops contained 2 μL of reservoir solution mixed with 2 μL of protein
solution (6.0 mg/mL AarC, 45 mM Tris•HCl, pH 8.0, 90 mM potassium chloride, either 10
mM CoA, 10 mM 1a, or 1–3 mM 2a ). Some drops contained 1–50 mM sodium acetate,
pH 8.2, instead of (or in addition to) a CoA analogue. Three d before cryoprotection,
sodium acetate (~50 mM final, added from a 1 M stock at pH 8.2) was gently added to
several drops containing crystals grown in the presence of 2a. Crystals were soaked for
13 h in a cryoprotectant solution containing 15% (w/v) sorbitol, 1.1 M sodium citrate, 0.1
M imidazole, pH 8.2, 25 mM 2-mercaptoethanol, and any additional ligands (each at 110%
of the concentration used for crystallization). No special measures were undertaken to
exclude microbial contaminants. Crystals were loaded into Nylon loops, flash-cooled by
rapid immersion in liquid N2, and kept at or below 100 K (Teng, 1990). X-ray diffraction
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data were collected at LS-CAT beamlines at the Advanced Photon Source at Argonne
National Laboratory. Diffraction data were indexed, integrated, and scaled using HKL2000
(Otwinowski and Minor, 1997).
Determination, refinement, and analysis of crystal structures.
Automatic and manual refinement were performed using PHENIX (Adams et al.,
2010) and Coot (Emsley et al., 2010), respectively. Ligand coordinates and restraints were
obtained from HIC-Up (Kleywegt, 2007) and modified using PHENIX.
All structures were solved using a hybrid model of translation-libration-screw (TLS)
groups and isotropic atomic B-factor (Biso) terms for all protein atoms. PHENIX analysis of
the 4eu9 coordinates was used to define a set of twelve TLS groups. The starting model
for direct refinement was protein atoms from AarC-R228E•CoA (PDB entry 4eu9)
coordinates, with initial Biso values set to 30 Å2 and minor alternative conformations set
to zero occupancy. Initial TLS refinement (15 cycles) (Merritt, 2012) was followed by
positional (Cartesian, real-space, and rigid-body) and ADP refinement (5 cycles). CoA or
an analogue was then added (except PDB entry 5dw4) and superfluous alternate
conformations were deleted using COOT. Subsequent refinement rounds omitted rigidbody refinement, added occupancy refinement, and were alternated with manual model
adjustments in COOT. Ligands, known buffer components, and hypothetical 1a
degradation products (smaller CoA analogues and, in one structure, a formate molecule)
were built into continuous difference electron density. Cys15 in some structures showed
evidence of sulfur oxidation and was modeled as cysteine sulfenic acid (CSX form; Furdui

57
and Poole, 2014). Riding hydrogens used during positional refinement steps were deleted
before a final round of ADP refinement (10 cycles).
Structures were checked using MOLPROBITY (Chen et al., 2010) and the worldwide
Protein Data Bank (Berman et al., 2003) validation pipeline (Read et al., 2011). Cavities
and pores were identified using MOLEonline 2.0 (Sehnal et al., 2013). Several figures were
prepared using Pymol (DeLano, 2002).
Stability of 1a and 2a.
A final volume of either 0.5 or 1.0 mL contained 50 mM potassium phosphate, pH
8.0, 100 mM KCl, 100 µM 1a, and 10 µM (subunit concentration) of either AarC (21.5
units, 0.28 mg or 43 units, 0.56 mg) or AarC-E294A (≤ 0.0043 units, 0.56 mg) was
incubated at 22 °C in a polypropylene microcentrifuge tube. One complete AarC reaction
mixture was sterile-filtered (surfactant-free cellulose acetate syringe filter with 0.22 µm
pores; Nalgene, Rochester, NY) to remove microbes and placed in a sterile, silanized
microcentrifuge tube (MidSci; St Louis, MO). A no-enzyme control and reaction mixtures
containing 10 µM 2a instead of 1a were processed in parallel. Aliquots (0.1 mL) were
withdrawn periodically, placed in a microcentrifuge tube, and heated in a sand bath
(95°C, 15 min). Solids were removed by centrifugation (16,000 g, 10 min), an ultraviolet
spectrum was recorded, and the clarified reaction mixture was stored at -20 °C. 2a
derivatives were quantitated using a Waters (Milford, MA) Breeze HPLC system equipped
with an Agilent (Santa Clara, CA) Zorbax Eclipse XBD-C18 column (4.6 x 150 mm, 5 µm)
and a Waters 717 autosampler. A portion of each quenched reaction mixture (20 µL) was
mixed with an equal volume of 10% trichloroacetic acid (TCA) and applied to the column,
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which was developed isocratically [200 mM sodium phosphate, 150 mM sodium acetate,
pH 4.6, adjusted to 2% (v/v) acetonitrile] at 26 °C at a flow rate of 1 mL/min with detection
at 260 nm. CoA analogues were identified by comparison to standard mixtures (run daily
to correct for variable retention patterns) and their concentrations were determined by
reference to the analogue peak area in an immediately quenched (t=0) complete reaction
mixture.
Additional small aliquots (2.7 μL) were periodically removed from reaction
mixtures, either containing or lacking 1a, and diluted to a final volume of 0.15 mL in
phosphate/KCl buffer with or without 10 mM sodium borohydride. After 10 min at 25 °C,
aliquots (5 μL) were removed and residual SCACT activity was measured in LCR assays
(Mullins et al., 2008).
Identification of acetate.
A 1 M, pH 8.0 acetate standard was prepared from solid sodium acetate. A final
volume of 20 µL contained 50 mM potassium phosphate pH 8.0, 100 mM KCl, 25 mM
MgCl2, 16 µL of either the quenched 1a degradation mixture or an acetate standard, 1.0
mM CoA, 1.8 mM ATP, and acetyl-CoA synthetase (0.004 units) at 22 °C. After 45 min, TCA
[20 µL, 10% (w/v)] was added and solids were removed by centrifugation (16000g, 10
min). Waters HPLC analysis (25 µL injections) revealed a single large peak, not present in
a control reaction mixture lacking acetyl-CoA synthetase that co-migrated with an
authentic AcCoA standard. AcCoA concentrations, determined by reference to AcCoA
standard injections, were taken to be the lower limit for acetate production in 1a stability.
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Quantitation of acetate.
A final volume of 70 µL in a microcentrifuge tube contained 50 mM potassium
phosphate pH 8.0, 100 mM KCl, 6.7 mM MgCl2, 10 µL of either a quenched 1a stability
assay reaction mixture or an acetate standard, 0.14 mM NADH, 1 mM ATP, 2 mM
phosphoenolpyruvate (PEP), H6AckA (3 units), pyruvate kinase (6 units), and lactate
dehydrogenase (6 units) at 22 °C. Reactions were initiated by the addition of H6AckA.
After 40 min, the entire reaction mixture was transferred to a black-walled microvolume
quartz cuvette (70 µL capacity) and a spectrum was recorded. Acetate concentrations
were determined by subtracting the absorbance at 340 nm (A340) of a control reaction
lacking H6AckA (Δε340 = 6.22 mM-1 cm-1).
MALDI-TOF analysis of 1a degradation products.
Quenched 1a stability assay reaction mixtures were thawed and an aliquot (1 µL)
was mixed with 9 µL 1% (v/v) formic acid. A portion of the acidified mixture (0.5 µL) was
mixed with 0.5 µL matrix solution (1 mg/mL α-cyano-4-hydroxycinnamic acid in 50%
acetonitrile and 0.1% TFA), deposited on a stainless steel MALDI plate, and air-dried for ~2
h. Analysis was performed in positive ion mode. Batch method cation exchange (PSE cation
exchange resin) and solid phase extraction using ZipTip pipette tips (Millipore) was also
attempted on 1a stability assay time points.
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3.3

Results

Parameterized active site conformations.
We have defined four stages in the closing of the AarC active site, ranging from
fully open (exemplified by AarC, PDB entry 4eu3) to fully closed (exemplified by AarCE294A•CoA, PDB entry 4eub) that engage, immobilize, and desolvate acyl-CoA substrates
and Glu294 adducts (Mullins and Kappock, 2012). Characteristic side chain conformations
for residues Arg228, Asn229, Phe232, and Val270 were associated with each stage to
catalogue the underlying complex dynamics and multiple roles of the 230s loop (residues
228-234) and the 270s loop (residues 270-274). Using external oxyanion hole component
Gly388 N as a fixed reference point, active site closure can be quantitatively described
using four interatomic distances that capture 230s loop motion (the sum of distances to
Asn229 CG and Phe232 CG), active site constriction (the distance to Val270 CB), and the
in/out conformations of Arg228 (the distance to Arg228 CG), which occur twice per halfreaction and are typically reciprocal to the movements of Asn229. This parametrization
groups closed conformations (cluster at lower left in Figure 3.3) and open conformations
(upper right in Figure 3.3) and allows ready identification of intermediate states such as
those associated with covalent enzyme adducts (e.g., the acetylglutamyl anhydride 4eu6A
and and the glutamyl-CoA thioester 4eu6B).
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Figure 3.3. Parametrization of AarC(H6) active site conformations. Each point represents
one subunit of AarC (PDB entry 4eud) or AarCH6 and its mutant forms (remaining points).
The values are derived from distances (d) between Gly388 N, a fixed reference point
within the active site, and the indicated atom(s) in a wild-type or mutant subunit. All
proteins crystallized in an orthorhombic lattice apart from 4eu4, which is in a hexagonal
lattice (Mullins and Kappock, 2012). Note that the two hexagonal subunits adopt almost
identical open conformations. The open conformations of subunit B in orthorhombic
crystals form a sub-cluster (upper right) due to crystal contacts described in the text. One
Val270 CB position was estimated for one minor conformer (5ddkA:a, diamond symbol)
using real-space refinement.
Different sub-clusters for subunit A and B open conformations (Figure 3.3) arise
from crystal-packing interactions in the orthorhombic lattice adopted in the majority of
AarC(H6) crystals. The loop containing Phe232B contacts helix alpha-4 in subunit A from
a neighboring asymmetric unit, which leads to a slightly larger separation of this region
from a reference point in each active site (the intra-subunit Phe232 CG-Gly388 N distance
is 21.7 ± 0.1 Å [n = 9] in subunit A and 24.9 ± 0.1 Å [n = 5] in subunit B). An open-
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conformation structure solved in a hexagonal lattice (PDB entry 4eu4) has no comparable
crystal-packing contacts and resembles orthorhombic subunit A (the Phe232 CG-Gly388
N distance is 21.9 Å for both subunits). The other three residues considered appear to be
unaffected by subunit-specific differences in crystal packing.
A misaligned nucleophile in AarC-N347A.
AarC-N347A lacks the carboxamide moiety proposed to contact the internal
oxyanion formed during thiolysis of the acylglutamyl anhydride intermediate (Figure 3.1).
The mutant retains appreciable (~15% of wild-type) specific activity (Mullins and Kappock,
2012). A data set obtained from a crystal grown in the presence of CoA was used to
determine a structure in an orthorhombic space group. Like all structures described here,
the protein fold and CoA binding site were the same as described previously (Mullins and
Kappock, 2012). Chloride ions were bound, as expected, near the pseudo-twofold axis or
between C-terminal domains of each subunit. Three imidazole ligands were also included
at the latter interface.
The final refined model (PDB entry 5ddk) contained alternate conformations for
both CoA ethanethiol moieties and residues Arg228A-Asp236A, with the major and minor
contributions from closed and open conformations, respectively. The subunit A 230s loop
conformations differ by tandem flips of the two peptide bonds to Asn229. The subunit A
270s loop adopted multiple conformations, with the closed conformation most abundant.
Difference electron density peaks consistent with the 270s loop open conformation were
observed but too weak to justify inclusion in the final model. All three regions in subunit
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B adopted the closed conformation. The differences in CoA complex structures for wildtype and mutant AarC (open and closed, respectively; subunit B) do not affect this region
of the active site (Figure 3.4).

Figure 3.4. Stereogram of the AarC-N347A active site. The B subunits of AarC-N347A
(PDB entry 5ddk, white carbon atoms) and AarC (PDB entry 4eu7, blue carbon atoms),
each bound to CoA, are superposed. Spheres are shown for ligand atoms in AarC-N347A.
The Glu294 carboxylate shifts by about the width of the carboxylate moiety, allowing a
different oxygen atom to interact with Gly388 N (separated by 0.33 Å here). The Glu294
rotamer changes from mt-10 (open) to tt-0 (closed), as illustrated here, but the closed χ3
value is unusual. Distances (Å) in blue show hydrogen bonds involving the Glu294
nucleophile, including one to the "new" HOH in the AarC-N347A•CoA complex. The
distance colored magenta depicts the motion of the Val270 CB between open (AarC)
and closed (AarC-N347A) conformations.
Since AarC-N347A retains significant activity, our hypothesis was that a polar
group would simply supplant the missing Asn347 carboxamide and restore its function.
As anticipated, an active site solvent molecule was observed at this location in each
subunit, with a lower B-factor in subunit B (HOH 775A and 787B: 58 and 34 Å2). The
solvent substitution, however, additionally appears to influence the conformation of
Glu294. While Glu294 in the N347A mutant adopts the tt-0 rotamer observed in other
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closed structures, its χ3 value is unusual, corresponding to a rotation of the attacking
oxygen towards the mutated residue (i.e., away from the CoA binding site). [Any value of
χ3 is permitted in the Glu tt-0 rotamer (Lovell et al., 2000).] The resulting misalignment of
the key nucleophile would decrease the probability of productive attack on an incoming
acyl-CoA substrate.
Since AarC-N347A appears to favor the closed conformation and potentially
substrate exchange, the deleterious effect of the mutant might also be a consequence of
impeded acyl-CoA dissociation and binding during steady-state turnover. We disfavor this
alternative hypothesis since all four N347A KM values are similar to wild-type AarC KM
values (Mullins and Kappock, 2012). Our working model therefore remains that Asn347
polarizes and positions Glu294, aiding in its roles as nucleophile and, potentially, as the
leaving group in the CoA thiolysis reaction. The principal impact of the N347A mutation
would therefore appear to be on enzyme-mediated, unimolecular chemical steps.
Conversion of 1a during crystallization with AarC.
The AcCoA ketone analogue 1a, in which the thioester sulfur atom is replaced by
a methylene group, was tested for its ability to form a hemiacetal analogue of the
tetrahedral hemithioacetal intermediate stabilized by the external oxyanion hole (Figure
3.5). Cleavage of a 1a-derived hemiacetal is prevented because an alkyl carbanion cannot
serve as a leaving group, affording a chance to study a stabilized external oxyanion. AarCE294A readily formed crystals containing 1a in a closed active site (PDB entry 4euc).
Structure comparisons led us to predict that a severe steric clash with the Glu294
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carboxylate (Figure 3.1, insert) would favor anhydride formation but might preclude
formation of a closed AarC•1a complex (Mullins and Kappock, 2012).

Figure 3.5. CoA analogues as probes of CoA-transferase mechanism. Left, reactions
involving the external carbonyl of the acetylglutamyl anhydride. Thiolate protonation is
possible but unlikely to be part of the normal reaction coordinate. Right, attempted
trapping of a tetrahedral external oxyanion intermediate. The atomic substitution in 1a
has comparatively small effects on electronegativity and sterics so could allow formation
of a hemiacetal intermediate resembling the external oxyanion and perhaps enable
insight into how its reactivity is modulated. The tetrahedral intermediate formed by
nucleophilic attack by AarC on the 1a carbonyl cannot be resolved into cleavage products.
The very high pKa of an unactivated alkyl methyl, perhaps 50, would preclude formation
of the alkyl carbanion required, even considering the exothermic subsequent
protonation.
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AarC was crystallized in the presence of 1a and its structure was determined
(Table 2; PDB entry 5e5h). Glu294A was modeled as a mixture of free carboxylate and
acetylglutamyl anhydride adduct in a 0.4/0.6 ratio, with a relatively narrow range of Bfactors. Since density associated with the 3'-phosphate was ambiguous and weak, the
large ligand in subunit A was modeled as 2b (Figure 3.2). Excess density was noted near
the 2'-hydroxyl that might be due to a minor contribution from a 2’-phospho isomer, 2c.
[Iso-CoA forms during the chemical synthesis of CoA (Burns et al., 2005).] The electron
density associated with the large ligand in subunit B did not extend beyond carbon atom
C3P,

so

it

was

modeled

as

3'-phosphoadenosine

5'-(O-(N-methyl-R-

pantothenamide))pyrophosphate (Figure 3.2; 4a). Unlike subunit A, convincing electron
density was associated with the 3'-phosphate group in subunit B, stabilized by the side
chain of Lys408B. An active site acetate ligand was also included in subunit B.
Subunit A (5e5hA) adopted an open conformation distinctly different from a
partially closed conformation observed for an AcCoA-derived acetylglutamyl anhydride
(PDB entry 4eu6A) (Figure 3.3). The former appears to be less able to shield a labile
acetylglutamyl anhydride from hydrolysis. Subunit B (5e5hB) adopted a partially closed
conformation similar to that observed for the glutamyl-CoA thioester adduct bound to
acetate (PDB entry 4eu6B) (Figure 3.3), even though 1a and truncated derivatives (e.g.,
2a and 4a) cannot form thioesters. An acetate contacting Ser71B OG was included in the
model.
Acetate observed previously in an AcCoA-soaked AarC crystal, in an active site
containing a glutamyl-CoA thioester (PDB entry 4eu6B), was presumed to arise

from
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AcCoA hydrolysis (Mullins and Kappock, 2012). No chemical process of which we are
aware could convert the ketone in 1a to 2a and acetate, let alone an acetylated molecule
capable of producing an anhydride. The apparent formation of an anhydride seems to
imply that AarC converts the 1a ketone into a two-carbon activated acetyl group, with the
remaining atoms forming 2a or a related compound. No CoA-transferase has been
reported to perform oxidation activity, suggesting that the conversion of 1a to an AarC
acylating agent may be due to an unknown contaminating enzyme or microbe.
Subsequent hydrolysis (n.b., not the normal thiolysis) of the anhydride would account for
the formation of acetate in subunit B. Positive evidence for these transformations cannot
be gleaned from electron density maps alone. We therefore attempted to obtain chemical
evidence for the formation of 1a -derived compounds. Partial disorder of the 1a ketone
did not appear to account for smaller ligand 2b. The “acetyl” moiety of 1a would clash
with Glu294, even in the relatively open subunit A. The closed active site of subunit B
would enforce even more stringent steric constraints on the bound ligand, which might
be a partially disordered 2a or 3a instead of the modelled 4a.
Attempted trapping of acetylglutamyl anhydride with sodium borohydride.
Borohydride can inactivate class I CoA-transferases supplied a valid substrate, by
reducing an activated Glu carboxylate thioester to 5-hydroxynorvaline (Solomon and
Jencks, 1969). While both the acylglutamyl anhydride (internal carbonyl) and glutamylCoA thioester adducts could be inactivated, 1a cannot form the latter. To test for
anhydride formation, AarC and 1a were incubated together for a week. Aliquots of the
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reaction mixture were withdrawn at intervals, mixed with sodium borohydride, and
tested for residual SCACT activity. No loss of enzyme activity was observed in this
experiment or in a control reaction lacking 1a (Figure 3.6). This finding suggests that no
anhydride adduct of AarC is present in solution, although the 5e5h structure suggests that
one may be stabilized by the crystalline lattice.

Figure 3.6. Attempted borohydride trapping of covalent adducts of AarCH6. Treatment
with reductant is expected to inactivate AarCH6 by irreversible reduction of either the
Glu294 acetylglutamyl anhydride or glutamyl-CoA thioester adducts. The latter has been
directly detected in a AarC mutant, presumably as a consequence of protein production
in E. coli (Mullins et al., 2008). Aliquots were withdrawn at the indicated times from either
1a stability assays or no- 1a controls and transferred to either 10 mM NaBH4 or a water
control. Specific activities are given relative to the zero-time point of a no- 1a control that
was not exposed to NaBH4 (black symbols; 100% = 112 units/mg). Other experiments
showed no time-dependent loss of SCACT activity: no 1a, 10 mM NaBH4 (red symbols;
missing t=0 point); 100 μM 1a, no NaBH4 (blue symbols), 100 μM 1a, 10 mM NaBH4
(purple symbols).
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Stability of 1a.
Direct detection of 1a cleavage by analysis of small molecules formed in AarC
crystal mother liquor was deemed to be infeasible. Instead, an 1a stability assay was
devised to detect the formation of truncated CoA analogues in reaction mixtures
containing AarC. Analogues 2a and 3a were synthesized for use as authentic standards
(Figure 3.7). HPLC chromatographic conditions that resolved 1a, 1c, and 2a were
identified (Figure 3.8). Under these conditions, the detection threshold for 2a (in the
presence of a ~20-fold molar excess of 1a) was ~0.02 nmol.
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Figure 3.7. LCMS analysis (negative ion mode) of CoA analogues 2a and 3a. (A) 2a showed
peaks at m/z 748 and 373.5, corresponding to singly and doubly deprotonated forms
(expected parent molecule mass 749.16 Da), presumably one or more of the phosphate
moieties. (B) 3a showed peaks at m/z 734 and 366.5, corresponding to singly and doubly
deprotonated forms (expected parent molecule mass 735.14 Da).
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Figure 3.8. HPLC analysis of synthetic 1a and 2a. A 9:1 mixture of 1a and 2a was injected
at t=0 and the absorbance profile at 260 nm was recorded (mA = milli AU). Conditions
were otherwise identical to those used to quantitate analogues in the 1a stability assay
(Figure 3.10). Peaks observed under these conditions were assigned using singlecompound injections: 1a, 15.4 min; 2a, 17.0 min; and 1c, 19.3 min.
The stability of 1a was assessed by serial HPLC analysis of reaction mixtures
incubated at ambient temperature. CoA analogues including 1a were identified by
retention time and 1a was quantitated by comparing its peak area to a reference reaction
mixture quenched immediately after the addition of enzyme.
First, 1a was incubated in buffer without added enzyme. Under these conditions,
1a was stable and no new peaks were observed in HPLC chromatograms, with 94–100%
remaining after 168 h (Figure 3.9).
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Figure 3.9. Active enzyme is not required for 1a degradation. Absorbance spectra or HPLC
analysis after heat quenching was used to monitor the decay of 1a (initially 100 µM) in
reaction mixtures containing: 10 µM AarCH6, magenta (HPLC) and green (A260) symbols;
10 µM AarCH6-E294A, black symbols; no enzyme, blue symbols; and 10 µM AarCH6 that
was sterile-filtered immediately after mixing, red symbols.
Second, 1a and AarC were incubated together at a 10:1 molar ratio (subunit
concentration). Delayed but complete loss of the HPLC peak corresponding to 1a was
observed (Figure 3.10). A parallel experiment monitoring the absorbance spectrum of
crude reaction mixtures showed a progressive decrease at 260 nm (Figure 3.9), consistent
with disintegration of the adenine moiety.
Third, 1a and the inactive mutant AarC-E294A were incubated together at a 10:1 molar
ratio. Delayed but incomplete loss of the HPLC peak corresponding to 1a was observed
(Figure 3.9), with ~37% remaining after 168 h. Therefore active enzyme was not required
for 1a degradation.
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Figure 3.10. Unfiltered reaction mixtures containing AarCH6 decompose 1a. Stability of
1a in a reaction mixture initially containing 10 µM AarCH6 and 100 µM 1a at room
temperature. Aliquots were withdrawn at the indicated time points and HPLC (1a, black
filled circles), AK-ATPase assay (acetate, red filled circles), and MALDI-MS analyses were
performed. The circles and error bars respectively depict average concentrations and
standard deviations for three independent time courses. An alternative time course using
ACS to detect acetate is shown in Figure 3.18.
Fourth, a reaction mixture containing 1a and AarC, using the same conditions as
the second experiment, was sterile-filtered shortly after mixing. After 168 h, 98% of the
original 1a was recovered, demonstrating that it is stable under these conditions.
Furthermore, this result suggested that 1a truncation is a microbe-mediated process. A
new peak observed in HPLC traces coincided with rapid loss of 1a (Figure 3.11). This lateeluting peak was collected, analyzed by MALDI-TOF MS, and found to have m/z = 712.13,
corresponding to an [M+H-Pi]+ ion (expected m/z 712.20) (data not shown). This
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compound was tentatively assigned as 3'-dephospho-AcMX (1b), and it appeared to be
preferentially formed from 1a not 1c (Figure 3.11). Peaks corresponding to 2a, 3a, or a
peak likely to correspond to 4a were not detected by HPLC analysis of 1a stability assay
reaction mixtures.
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Figure 3.11. Transient formation of 1b. (A) Sequence of HPLC chromatograms for a
representative 1a degradation time course. The peak at 29.4 min was found to contain a
species consistent with 1b, with m/z = 712.17 (Figure 3.13); m/z = 712.21 expected
(C24H40N7O14P2+). 2a was not detected in this or other HPLC experiments. (B) Peak
areas for the chromatograms shown in panel A (total t=0 peak area set arbitrarily to 100):
1a, black symbols; 1b, red symbols; 1c, blue symbols; total peak area, magenta. 1b
appears to be formed primarily from 1a not 1c.
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Stability of 2a.
One potential explanation for the failure to detect 1a -derived 2a in solution
stability assays would be rapid degradation of 2a. Conversely, 2a present in a crystal might
be protected from degradation. The solution stability of 2a was assessed as described for
1a. In unfiltered reaction mixtures containing AarC, 2a decomposed completely, with an
initial lag ~24 h longer than that observed for 1a (Figure 3.12). The substitution of inactive
AarC-E294A did not prevent degradation, but 2a was stable in a no-enzyme control.
A microbe-mediated 2a degradation process was again suggested by the correlated loss
of the 2a HPLC peak and the adenine chromophore (data not shown). We concluded that
rapid 2a decomposition could explain why it was not detected by HPLC, since only a small
amount of 2a may accumulate. We next attempted to detect 2a using sensitive but nonquantitative MS techniques.
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Figure 3.12. 2a decomposes in unfiltered reaction mixtures containing AarCH6. HPLC
analysis after heat quenching was used to monitor the decay of 2a (initially 10 µM) in
reaction mixtures containing: 10 µM AarCH6, magenta symbols; 10 µM AarCH6-E294A,
black symbols; no enzyme, blue symbols. Only the no-enzyme control contained
detectable 2a after 96 h (detection threshold 1 µM).

Identification of 1a-derived compounds containing adenine.
MALDI-TOF analysis of 1a stability assay reaction mixtures was used to detect 1aderived compounds (Table S1). Spectra acquired over 168 h showed an increasing
proportion of species with smaller m/z values, many of which were not identified. The
largest new peaks (m/z 712, 750, and 788) corresponded to the [M+H]+, [M+K]+, and
[M+2K]+ ions of 1b (Figure 3.13). This trio of peaks was only detected at 48, 72, and 96 h
(Table S1), as expected for a transient intermediate in a multi-step 1a degradation
process. Since the 1b [M+K]+ and 2a [M+H]+ ions are isobaric (expected m/z 750.17),
MS/MS daughter ion fragmentation patterns were recorded and compared to those for
authentic 1a (Figure 3.14) and 2a (Figure 3.15) standards. A MS/MS spectrum of the m/z
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750.17 peak observed at 96 h in a 1a stability assay contained several daughter ions unique
to 1b but none unique to 2a, together with daughter ions that could derive from either
compound (Figure 3.16). In addition, several prominent daughter ions in the synthetic 2a
spectrum (Figure 3.15) were not detected. While we cannot rule out the possibility of a
small amount of 2a formation, 1b is the best assignment of the m/z 750.17 ion.
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Figure 3.13. MALDI-TOF detection of compounds formed during 1a decomposition.
Spectra (positive ion mode) obtained using complete reaction mixtures from t=0 (blue
spectrum) and 96 h (red spectrum) are superimposed. Boxes highlight 1a peaks and circles
new peaks consistent with the production of 2a (expect m/z 750.17 for [M+H]+, m/z
788.12 for [M+K]+) or 1b (expect m/z 719.21 for [M+H]+, m/z 750.17 for [M+K]+). Note
that the 2a and monopotassium 1b ions are isobaric. These peaks were only detected at
48, 72, and 96 h.
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Figure 3.14. MS-MS spectrum of synthetic 1a.
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Figure 3.15. MALDI-MS/MS (positive ion mode) fragmentation of a m/z 750.17 ion
obtained from synthetic 2a. Potential daughter ion structures, chemical formulae, and
computed m/z values are provided for prominent peaks. Protonation is presumed to
occur at adenine N1 (pKa ∼3.6; Kapinos et al., 2011) in daughter ions that possess an
adenine ring, but is speculative for others.
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Figure 3.16. MS/MS analysis of a candidate 1b ion formed during 1a decomposition. 2a
and monopotassium 1b (Figure 3.13) give isobaric parental ions (m/z 750.17). To
discriminate between these possibilities, an MS/MS spectrum of the 750.17 ion was
obtained from the 96 h sample (red spectrum, Figure 3.15). The observed MS/MS
spectrum is a poor match to the MS/MS spectrum of synthetic 2a (Figure 3.15).
Speculative structures for selected potassium 1b daughter ions are given.

83
As a preliminary test of whether 1b is an obligatory intermediate in 1a
decomposition, CoaE (dephospho-CoA kinase) and ATP were added to a 1a stability assay.
After 196 h, 98% of the original 1a was recovered, compared to 27% in a reaction mixture
lacking CoaE and ATP, and 105% of a no-enzyme control. The protective effect of CoaE,
together with kinetic evidence that 1c is a non-preferred substrate (Figure 3.11), is most
consistent with 1a dephosphorylation as the first step in 1a decomposition.
MS spectra were searched for ions consistent with known or hypothetical
compounds that might be produced during 1a decomposition. This was hampered by a
mass ambiguity: the replacement of a phosphoryl group with a hydrogen leads to a loss
of 80 amu, as does the replacement of an acetyl group and a potassium with two
hydrogens. Attempts were made to eliminate these ambiguities by cation exchange and
solid phase extraction. Both attempts resulted in loss of all previously detected ions (data
not shown). As one consequence of the mass ambiguity, the all-protonated 2a ion is
isobaric with the monopotassium 1b ion (Figure 3.13). First, we looked for ions that
appeared during the course of 1a decomposition that would be consistent with
shortening of the aminopentanone moiety in 1a or 1b. Singly charged ions (containing 0,
1, or 2 potassium atoms) consistent with 3a, 4a, or dephosphorylated (Figure 3.2; 3b and
4b, respectively) products were not detected. We also did not identify ions consistent
with oxygenated (+14 or +16 amu) forms of 3 or 4 (Table S1). Second, we searched for any
other ions that appeared during the course of 1a decomposition. MALDI-TOF spectra
acquired at 48, 72, and 96 h also contained new peaks at m/z 766 and 804 (Table S1),
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which were consistent with either (a) [M+K]+ and [M+2K]+ ions of 1b plus an oxygen atom
or (b) [M+H]+ and [M+K]+ ions of 2a plus an oxygen atom. (Potential structures for these
ions are discussed below.) We conclude that, if progressive shortening of the 1a or 1b
aminopentanone moiety occurs, many or all subsequent degradation steps are rapid and
appear to prevent accumulation of detectable levels of chain-shortened intermediates.
Identification of 1a-derived acetate.
Acetate from an unknown source was tentatively detected in the crystal structure
of AarC crystallized with 1a. Removal of the terminal two carbon atoms from 1a (or 1b)
might result in the formation of acetate. On the basis of this consideration, we performed
two sets of experiments intended to (1) unambiguously identify acetate as a product of
1a degradation and (2) maximize acetate recovery, to estimate the stoichiometry of
acetate production from 1a.
In the first set of experiments, ACS was used to convert acetate to AcCoA, which
was in turn positively identified by HPLC retention time and quantitated by comparison
to an authentic AcCoA standard (Figure 3.17). An acetate standard solution was used to
determine that this assay method recovers 92% of the original acetate as AcCoA (data not
shown), with losses presumed to originate from sample processing and transfer steps.
After 168 h, approximately 40 µM acetate was produced, corresponding to a 40% yield
(uncorrected) relative to the initial 1a concentration (Figure 3.18). No other acyl-CoA
peaks were detected in HPLC chromatograms. This experiment is highly specific for
acetate and places a lower limit on the stoichiometry of acetate recovered from 1a.
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Figure 3.17. Acetate is produced during 1a decomposition. ACS was used to convert
acetate present in 1a stability assay reaction mixtures to AcCoA, which was in turn
unambiguously identified by HPLC analysis. Unambiguously identifying acetate
production. Blue trace, chromatogram obtained using an authentic AcCoA standard. Red
trace, chromatogram demonstrating ACS-mediated formation of AcCoA from 1a stability
assays (96 h time point).

Figure 3.18. Alternative method for quantitation of acetate produced from 1a. Intact 1a
was detected and quantitated by HPLC in three independent time courses (open squares
of different colors). The average [1a] is depicted here with a magenta line, and in Figure
3.7 with a line and error bars. The blue filled circles depict acetate detected using ACS in
aliquots from 1a stability assay (green open squares).
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In the second set of experiments, AK was used to convert acetate and ATP to acetyl
phosphate and ADP, which was quantitated using a standard PK/LDH coupled ATPase
assay. A set of standards demonstrated quantitative recovery of acetate, a detection limit
of 0.1 nmol acetate (1–2% of the initial 1a, and linearity to at least 100 µM acetate (Figure
3.19). Decomposition reaction mixtures analyzed with a no-AK control showed negligible
NADH oxidation. Acetate was detected after 20 h of 1a incubation and reached a
maximum at 168 h, corresponding to a 88% yield relative to the initial 1a concentration.
As a one-pot assay, this assay minimizes sample losses but does not rule out the possibility
of uncoupled ATP hydrolysis or that alternate substrates for coupling enzymes are
produced during 1a breakdown. This experiment therefore places an upper limit on the
stoichiometry of acetate recovered from 1a breakdown.
To identify the source of acetate, 2a (100 µM) was allowed to degrade and
products were analyzed using the quantitative (AK-coupled) method. After 168 h, 80% of
the 2a was gone, but little or no acetate was produced: ~5 µM, or 5% of the initial [2a].
Given an uncertainty of perhaps 10 µM, the evidence from this preliminary experiment
indicates that 2a does not serve as a source of acetate. We therefore infer that the nearstoichiometric conversion of 1a to acetate requires a microbe-mediated cleavage of the
aminopentanone moiety, and may involve excision of the terminal two-carbon unit.
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Figure 3.19. Linear response of acetate determination assay. A standard acetate solution
was analyzed using the AK-dependent PK/LDH ATPase assay. A final volume of 70 µL
contained 0→100 µM acetate (0→7 nmol acetate total). The ΔA340 value recorded in the
zero-acetate sample was used as a background for the other concentrations (symbols). A
linear fit to the data, forced to pass through the origin, has slope 0.981 ∓ 0.009 (solid line).
Crystallization of AarC with acetate.

Acetic acid or acetate (collectively "acetate") has been observed in several AarC
structures without being provided in the crystallization solution. A. aceti normally
contains high levels of cytoplasmic acetate (Menzel and Gottschalk, 1985; Steiner and
Sauer, 2003), which is therefore likely to be the predominant protein-associated small
anion. We crystallized AarC with exogenous acetate to identify potential binding sites for
1a-derived acetate (PDB entry 5dw4). The final model contained three acetate binding
sites in each subunit, related by the pseudo-twofold axis.
The first acetate binding site is near the active site and has been observed to bind
acetate formed by AcCoA hydrolysis (PDB entry 4eu6 subunit B). Acetate (ACT 606A and
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603B) accepts hydrogen bonds from the side chains of Ser71, Thr94, and Arg228 (Mullins
and Kappock, 2012). This is the only acetate binding site not located at the rather polar
interface between subunits.
The second acetate binding site overlaps a chloride binding site (CL 515) observed
in earlier structures and is located on the flanks of the dimer. Acetate (ACT 605A and ACT
605B) accepts hydrogen bonds from the side chains of Asn112, Arg120, and Asn125 of the
same subunit and the backbone of Gly443' (the prime denotes a residue from the partner
subunit).
The third acetate binding site overlaps the other chloride binding site (CL 516)
observed in earlier structures and is located near the pseudo-twofold axis on the flat "top"
of the dimer. Acetate (ACT 607A and 601B) accepts hydrogen bonds from the side chains
of Arg354 (bidentate) and Arg354' (monodentate) and the backbone NH of Val196'.
Protein atoms in the interfacial acetate and chloride binding sites are nearly
superimposable, indicating that the acetate displaces chloride ions supplied by the
buffers used to isolate and crystallize recombinant AarC(H6).
Acetate crystals lacked the buffer-derived citrate ligands observed in earlier
"open" structures (PDB entries 4eu3, 4eu7, and 4eud). As anticipated, each subunit in the
AarC•acetate complex possesses active site parameters typical of other open
conformations (Figure 3.3).
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Crystallization of AarC with 2a.
Crystallography cannot unambiguously identify 2a as the ligand in AarC crystals
grown with 1a (denoted AarC+1a). The putative 2a propyl sidechain has relatively high Bfactors, as expected for a flexible, nonpolar group in an open, polar active site (PDB entry
5e5hA). AarC was crystallized with synthetic 2a to compare an authentic AarC•2a complex
with the AarC+1a structure. AarC•2a•acetate crystals were grown either with acetate
present in the initial crystallization solution or with acetate added long after AarC•2a
crystals formed. Several X-ray data sets were collected using crystals from drops that
initially contained either 2a or 2a+acetate; all diffracted to 1.66 Å resolution. A better
data set (PDB entry 5dw6) was obtained from a crystal that was grown in the presence of
2a prior to the addition of acetate.
The AarC•2a complex (PDB entry 5dw5) contained three chloride ions, one near
the pseudo-twofold axis and two on the flanks of the dimer. One of the latter chlorides
(CL 601A) and an acetate ligand (ACT 601B) were located so close together we assumed
that they could not be simultaneously present. The final refined fractional occupancies
were 63% and 37%, respectively. The acetate orientation was different from that
observed in the AarC•acetate complex (PDB entry 5dw4): it accepted a hydrogen bond
from the side chain of Asn112A. Since acetate was not intentionally added to this crystal,
we considered but ultimately discarded the possibility that a formate was carried over
from the isolation of 2a. Other aspects of the structure were essentially the same as
described next for acetate-soaked crystals, other than replacing chloride ions associated
with two different sites in each subunit (Mullins and Kappock, 2012). An acetate-capped,
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solvent-filled tunnel provides a possible path for entry of two buried acetates near the
pseudo-twofold axis.
The AarC•2a•acetate complex (PDB entry 5dw6) contained 2a and an acetate in
each active site, with four acetate ligands at the subunit interface (two on the flanks of
the dimer and two at the pseudo-twofold axis). Subunits A and B adopt the open and
closed conformations, respectively (Figure 3.3). An in-plane ~120° rotation of the activesite acetate ligand in subunit B, relative to previous orientations (e.g., PDB entry 4eu6),
gave a slightly better fit to the data. This may be related to the exclusion of the
carboxylate-binding residue Arg228B from the closed active site. A bow-shaped, 65 Å
long, narrow (average width ~2 Å), and hydrophilic tunnel was plugged by the two flankbinding acetates that supplant chloride ions (Figure 3.8). Eight basic and zero acidic
residues line the tunnel, but only the acetate binding sites have a substantial positive
charge. Crystals containing 2a, including those grown without added acetate, did not
contain ordered citrate ligands, even though subunit A adopts an open conformation and
the crystallization conditions were, apart from CoA, identical to those that yielded
AarC(H6) crystals with a citrate in each active site (PDB entries 4eu7 and 4eud).
The CoA analogue 2a binds in the same orientation in the two active sites (Figure 3.20),
which is notable because one is open (subunit A) and the other is closed (subunit B). In
the fully closed conformation, a hydrogen bond was observed between Val270
carbonyl and the OAP hydroxyl in the pantoic acid moiety of 2a. Relative to the AarC+1a
structure (PDB entry 5e5h), the 2a propyl group is closer to a fully extended conformation;
the orientations differ by a 107° rotation about the C2P–C3P bond. The terminal group
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that is modeled as a methyl in the 1a-derived molecule has a close contact with the
nearest carboxylate oxygen atom in Glu294A (3.1 Å). In contrast, the structure containing
authentic 2a adopts an almost perpendicular conformation that buries the terminal
methyl in a largely hydrophobic region ~4 Å from Gln267A CG, Glu294A CG, Gly388 CA,
and the Phe392 phenyl ring. Density associated with the 3' phosphoryl was unambiguous
for the AarC•2a(•acetate) structure but not for the 1a-derived molecule. In summary,
AarC crystals grown with chemically defined ligands including 2a did not recapitulate the
structure obtained with 1a under conditions associated with its decomposition. This likely
arises from differences in crystallization kinetics and conditions or the presence of
different ligands. We favor the latter as a working hypothesis, as the terminus of the 1aderived ligand appears to be more polar and perhaps somewhat larger than the
aminopropyl group in 2a.
Attempts to crystallize AarC with 3a, with and without exogenous acetate, yielded
only clear drops devoid of crystals.
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Figure 3.20. Stereograms of the AarCH6●2a●acetate active sites. (A) Subunit A, in the
open conformation for all structures depicted. Carbon atoms in superposed B subunits
are green in AarCH6●2a●acetate (PDB entry 5dw6; spheres are shown for 2a and HOH
923A), wheat in AarCH6+1a (PDB entry 5e5h), and light blue in AarCH6●citrate (PDB entry
4eu7). (B) Subunit B, in the closed conformation except where indicated. Carbon atoms
in superposed B subunits are green in AarCH6●2a●acetate (PDB entry 5dw6; spheres are
shown for 2a and HOH 713B), salmon in AarCH6-E294A●1a (PDB entry 4euc), and light
blue in AarCH6●citrate (PDB entry 4eu7, open conformation). Distances (in dashed lines)
are shown for 5dw6 hydrogen bonds and the shift of Val270B CB from the open to closed
conformation (magenta). The orientation is the same as Figure 3.4.
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3.4

Discussion

Enzyme substrates that incorporate large cofactors, such as acyl-CoAs, form
extensive protein-ligand interfaces that can increase substrate specificity, enzyme
reaction rates, and thereby metabolic flux. For example, bacterial biosynthetic enzymes
recognize NADPH, against a 20-fold excess of NAD+ (Bennett et al., 2009), using its remote
3'-phosphate. Nonreactive regions of a large substrate contribute "intrinsic binding
energy" that enzymes such as the CoA-transferases may exploit in catalysis (Jencks, 1975).
Jencks and co-workers showed that remote interactions further accelerate successive
acyltransfer and thiolysis reactions (Moore and Jencks, 1982a) initiated by tight clamping
of the acyl-CoA thioester by the enzyme (White and Jencks, 1976). This prediction was
later confirmed by crystal structures showing progressive constriction of the AarC active
site (Mullins and Kappock, 2012).
Analogue studies show that the ADP and pantoate moieties of CoA have opposing
effects on glutamyl-CoA thioester stability: the nucleotide supplies binding energy used
to pull the pantoate moiety into the active site and form a thioester whereas subsequent
interactions between the enzyme and pantoate moiety are destabilizing and increase
thioester reactivity toward carboxylates (Whitty et al., 1995). A substrate split into
"pieces" can sometimes form an alternative Michaelis complex that undergoes chemical
conversion (Amyes and Richard, 2013). Class I acyl-CoA transferases, however, fail this
test: only a covalently linked ADP moiety confers a rate increase (Fierke and Jencks, 1986).
This suggests that substrate conformational dynamics and mechanical coupling within the
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ligand are important aspects of harnessing binding affinity to achieve catalytic rate
accelerations.
Analogue studies have not yet explained how CoA-transferases productively
engage valid acyl-CoA substrates but discriminate against unproductive interactions with
free CoA, which possesses nearly all of the same features (Fierke and Jencks, 1986). Most
interactions of free CoA with the open conformation of AarC are mediated by waters that
are squeezed out when the active site closes, with a corresponding gain in entropy
(Mullins and Kappock, 2012). One practical advantage of this inability to close the active
site, and thereby assemble a functional active site, is that free CoA is not a strong enzyme
inhibitor (Blair, 1969); inhibition of AarC by CoA is competitive (Ki = 16 µM) and
comparable to acyl-CoA substrate KM values (Mullins, 2012). In addition to the important
role the "viselike grip" exerted in the immediate vicinity of the acyl-CoA thioester has on
catalysis (White and Jencks, 1976), we suggest that AarC, and by extension other class I
CoA-transferase active sites, positively recognizes free CoA to prevent the final stage of
active site closure.
Distinguishing CoA from acyl-CoA.
Conformational dynamics regulate CoA-transferase chemistry, since only
completely closed complexes contain both a complete external oxyanion hole and
properly oriented Val270, which are needed to initiate reactions with acyl-CoA substrates.
A key to furthering the understanding of CoA-transferases is therefore to generate
crystals containing closed active sites, using mutant enzymes or substrate analogues that
cannot undergo a complete enzymatic reaction.
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In our first set of AarC structures (Mullins and Kappock, 2012), we observed
complete active site closure but only in complexes of mutants with, among other effects,
enlarged active site pockets (S71A or E294A in PDB entries 4eu8B, 4eub, and 4euc; Figure
3.3). The most closed structure of wild-type AarC bound to CoA (PDB entry 4eu5B) shows
Val270 in a closed conformation, Arg228 in the open (inward) position, and the 230s loop
in an intermediate location (Figure 3.3). Crystal-packing interactions characteristic of the
subunit B active site may bias the protein conformation and favor formation of a Val270
amide-CoA thiolate contact.
In the current work, we have used substrate analogues to trap closed complexes.
While co-crystallization of AarC with 1a gave ambiguous results, the attempt to reproduce
this complex with authentic 2a yielded the first completely closed complexes of the wildtype enzyme (PDB entries 4dw5B and 4dw6B; Figure 3.3). The position of Glu294,
buttressed by Asn347, remains largely unchanged in the closed complex, lending further
support to the idea that enzyme closing exerts mechanical forces that favor attack of the
nucleophile with the acyl-CoA substrate (inset, Figure 3.1). Other polar groups within the
active site, such as the mobile Val270 residue, occupy locations that are consistent with
roles in catalysis proposed previously. Moreover, these residues adopt similar
orientations in crystal structures of mutant AarC complexes. By pre-positioning the
Val270 amide that is proposed to stabilize the CoA thiolate leaving group, the enzyme
facilitates reactions involving the key acylglutamyl anhydride intermediate.
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In PDB entry 4eu6A, the CoA thiol(ate) adopts a near-attack position equidistant
from the external and internal carbonyl carbon atoms of a trapped acetylglutamyl
anhydride. In 2a complexes, an inward rotation of the C2P-C3P bond moves the
corresponding methyl terminus into a small pocket in both open (PDB entries 4dw5A and
4dw6A) and closed (PDB entries 4dw5B and 4dw6B) complexes (Figure 3.4). A CoA sulfur
forced into this pocket would encounter electrostatic clashes with electron-rich carbonyl
oxygen atoms in Gly388 and the Glu294 carboxylate. The 2a terminus is rotated by ~120°
relative to the outward-facing CoA thiol(ate) observed in open active sites and the mostly
closed active site (PDB entry 4eu5B). In this location, the 2a methyl terminus appears
unlikely to affect active site conformational dynamics. A detailed comparison shows that
other regions of bound CoA and 2a adopt the same conformations. Similarly, there are
few differences in the protein region between CoA and the surface-located 230s loop that
might account for the more-open conformation of the latter.
The principal difference seems to be whether the ligand makes a polar contact
with the Glu294 carboxylate, an interaction that we propose "props open" the active site
and inhibits the final steps in active site closure. In PDB entry 4eu5B, the outwardly
rotated CoA sulfur atom is 2.9 Å from the closest Glu294B carboxylate oxygen atom, 3.4

Å from the Val270 nitrogen atom, and 12 Å from the closest guanidinium nitrogen atom

of the inward-facing Arg228B. Since a CoA thiolate could not form so close to a

carboxylate, a CoA thiol may be stabilized by a hydrogen bond involving Glu294. No such
interaction is possible in the fully closed complexes observed for AarC-E294A•CoA (PDB
entry 4eub), AarC-E294A•1a (PDB entry 4euc), or AarC•2a (PDB entries 4dw5/6B).
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Maintaining CoA at the proper cytoplasmic concentration and relative ratio to the
acyl-CoA pool allows effective carboxylate utilization and regulates flux through central
metabolism (reviewed recently by Hentchel and Escalane-Semerena, 2015). The ability to
positively recognize CoA and prevent diversion of its binding energy into the formation of
a dead-end closed complex would therefore confer an evolutionary advantage on diverse
CoA-transferases. Positive and highly specific selection for CoA binding could also explain
why oxy-CoA is more potent than CoA as an inhibitor of mammalian succinyl CoA:3ketoacid CoA-transferase (Jencks, 1973).
The mechanism by which a single polar contact might prevent the distant 230s
loop from fully closing may involve protein-ligand dynamics sensitive to the CoA thiolcarboxylate contact. The failure of "split substrates" to support efficient CoA-transferase
catalysis similarly implicates dynamic effects of an intact CoA moiety as a regulator of the
open/closed protein conformational equilibrium.
Internal oxyanion hole residue Asn347 reinforces Glu294.
Oxyanion holes are typically rigid features tasked with precise dipole positioning
(Kamerlin et al., 2010). The AarC-N347A mutant was designed to perturb the internal
oxyanion hole and thereby to slow enzyme chemistry, which is not rate-limiting in wildtype enzyme steady-state kinetics (White and Jencks, 1976). A relatively high residual
activity (Mullins and Kappock, 2012) suggested that an additional active site water might
restore the function of the mutated internal oxyanion hole. Ordered waters observed
near the site of each missing carboxamide appear to confirm this suspicion, which
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indicates that AarC-N347A cannot be used to completely stop CoA thiolysis nor
preferentially stabilize acylglutamyl anhydride intermediates. The crystal structure
suggests that Asn347 orients and thereby affects the function of Glu294 in multiple roles:
as nucleophile, part of internal oxyanions, and in positioning external oxyanions. While
these findings are consistent with our prior hypothesis that the N347A mutant primarily
affects enzyme chemistry, it now seems more likely that reactions at both anhydride
carbonyls are affected, not just those involving the internal carbonyl.
Two large families within the class I CoA-transferase superfamily have different,
highly conserved carboxamide residues, which suggests that the internal oxyanion hole is
more tolerant of variation than the strictly conserved external oxyanion hole. One
potential reason for this difference is that the internal oxyanion hole is preorganized
whereas part of the external oxyanion hole is mobile, delivered by the CoA itself, and
must adopt the correct configuration prior to or during active site closure (Mullins and
Kappock, 2012). In addition, the covalent attachment of Glu294 to the rigid C-terminal
beta-sheet may limit the intrinsic flexibility of the anhydride internal carbonyl, thereby
increasing its reactivity relative to the distal external carbonyl.
A working hypothesis for 1a cleavage.
The class I CoA-transferase external oxyanion hole is composed of two amide
dipoles, the backbone nitrogen of Gly388 and the distal amide nitrogen of the substrate
itself (Mullins and Kappock, 2012). We hypothesized that 1a, a competitive inhibitor that
binds tightly to AarC (Ki = 17 µM, Kd = 0.8 µM; Mullins et al., 2008), could be used to trap
a stable hemiacetal analogue of the external oxyanion in a fully closed active site. This
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experiment was thwarted by unexpected microbe-mediated truncation of the substrate
analogue, which ultimately resulted in complete consumption of the organic ligand.
(Attempts to crystallize the hemiacetal complex under sterile conditions are ongoing.)
Since 1a degradation is slow and follows a long lag period, it was not previously detected
during routine activity assays but it was remarkably reproducible: 1a degradation was
observed in eight out of nine trials with independently purified batches of AarC or an
inactive mutant, indicating that 1a cleavage has nothing to do with AarC activity. We
speculate that the lag in 1a degradation is due to the induction of microbial enzymes,
including the postulated 3'-phosphatase.
We prepared AarC•2a crystals in an attempt to positively identify the 1a-derived
species, but instead obtained a fully closed complex (discussed above) that was distinctly
different from the partly open complex obtained from AarC and 1a. One explanation
might be the presence of a 3'-phosphate moiety in 2a, which was missing in at least one
subunit of the structure derived from AarC and 1a. We discount this explanation, given
that the 3'-phosphate is largely solvent-exposed and prior work that indicates that it has
little influence on substrate affinity (Whitty et al., 1995; Mullins and Kappock, 2012). A
more likely explanation for the difference is the absence of an acetylglutamyl anhydride
from the AarC•2a crystals; crystals obtained from AarC+1a adopt an intermediate
conformation characteristic of other covalent adducts (Figure 3.3, lower right quadrant)
that may protect the labile anhydride. Indeed, the absence of a CoA thiolate in 2a would
facilitate anhydride hydrolysis, particularly in solution, which could explain why the
borohydride-trapping treatment failed to detect anhydride adducts.
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The observation of an acetylglutamyl anhydride in the crystalline lattice (PDB
entry 5e5h) and the direct detection of acetate production in solution from 1a but not 2a
indicate that the 1a ketone is converted to an activated acetyl donor. Oxidation of 1a or
a degradation product by at least one microbial enzyme provides a straightforward and
concise, albeit speculative, route to an activated acetyl group: a Baeyer-Villiger
monooxygenase (BVMO) acting on 1a could yield ester 5a (Figure 3.21). Short-chain alkyl
methyl ketones that resemble the aminopentanone terminus of 1a are converted to
acetate esters by a Pseudomonas BVMO (Onaca and Kieninger, 2007).
Intriguingly, while 5a resembles AcCoA and would be well-suited to acylate
Glu294, the product alcohol 6a (Figure 3.21) could not perform subsequent steps in the
AarC reaction. For example, 6a would be less nucleophilic than CoA, which might
selectively stabilize the acetylglutamyl anhydride and account for its detection by
crystallography. The near-stoichiometric appearance of acetate and disappearance of 1a
in solution studies is also consistent with irreversible conversion of 1a to an activated
acetyl donor (Figure 3.7).
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Figure 3.21. Speculative pathway for 1a degradation by microbial enzymes. The key step
would be oxidation of the 1a ketone carbonyl by a Baeyer-Villiger monooxygenase
(BVMO), yielding 5a. Unlike 1a, 5a contains an activated acetyl moiety capable of
producing both an acetylglutamyl anhydride adduct (Figure 3.6) and free acetate (Figure
3.10). The other product of acyl transfer, 6a, appears to be degraded rapidly by undefined
enzymes. The intermediate detection of 1b suggests that a 3’-phosphatase (3’-pase) may
compete with, or form the substrate for, BVMO. Mass spectrometric evidence supporting
the first alternative, parallel pathways for 1a degradation, is detailed in Figure 3.22.
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Figure 3.22. Speculative pathways for 1a degradation by microbes. If BVMO is present, it
could act on either 1a or 1b. m/z peaks indicated with an asterisk were detected in spectra
other than t=0, italicized values were detected at time points including t=0, and normal
text were not detected.
The terminus of the 1a-derived CoA analogue, presently modeled as an alkyl chain
(PDB entry 5e5h), occupies a more open active site and a more polar region than the
terminus of authentic 2a. These discrepancies might be explained if the former is actually
6a with a partially disordered alcohol terminus. Finally, the possibility that 5a can form a
long-lived anhydride intermediate suggests future experiments with authentic 5a or Oacetyl oxyCoA, an analogue with one fewer methylene. AarC acylating reagents like these
may enable the stoichiometric preparation and trapping of fully closed, covalently
modified enzyme active sites.
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CHAPTER 4. PROTON EXCHANGE WITHOUT CONDENSATION IN
ACETOBACTER ACETI CITRATE SYNTHASE

4.1

Introduction

The citrate synthase (CS) condensation reaction joins the terminal methyl carbon
of acetyl-CoA (AcCoA) to the carbonyl carbon of oxaloacetate (OAA). An aspartate serves
as the general base and, together with a histidine, stabilizes the resulting AcCoA
carbanion/enolate nucleophile (Figure 4.1A). The subsequent citryl-CoA (CitCoA)
hydrolysis reaction forms citrate and CoA. As the gateway to central carbon metabolism,
CS catalyzes one of the most significant carbon-carbon bond-forming reactions in the
biosphere, one that is particularly important to energy harvesting by aerobes. The
condensation reaction performed by CS and the mechanistically related malate synthase
requires a weak base (a carboxylate) to somehow overcome the substantial kinetic and
thermodynamic barriers associated with carbon deprotonation (Gerlt and Gassman,
1993; Gerlt, 2007; Amyes and Richard, 2007) to generate and stabilize a carbanion prior
to carbon-carbon bond formation (Clark et al., 1988).Exchange of substrate hydrogen
atoms for deuterium atoms, most often provided by bulk D2O solvent, was the first, and
remains the most common, method used to detect transient carbanion intermediates
(Rose, 1958). In D2O solvent, CS catalyzes hydrogen- to-deuterium exchange (HDX) of the
Declaration of collaborative work: Hong Jiang measured the rate of HDX catalyzed by AaCS•OAA by NMR, Sandra Kerfoot measured
the rate of HDX by ESI-MS, Charles Constantine made single Trp mutants, and Julie Francois measured inhibition constants of AcCoA
analogues. All other biochemical experiments and analysis were done by Jesse Murphy.
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terminal methyl protons in AcCoA (Figure 1B) if OAA or an analogue such as D-malate is
also present (Marcus and Vennesland, 1958; Bové etal., 1959; Srere, 1967; Efferer, 1965;
Myers and Boyer, 1984; Kurz et al., 1997). Exchange is detected only in one methylene
of the product citrate, not in free AcCoA, suggesting that proton transfer commits bound
substrates to catalysis (Kurz et al., 2000). Active site residues, including several within the
pig CS (PCS) binding site for OAA, affect the rate and extent of HDX (Kurz et al., 1995; Kurz
et al., 1998). The nonhydrolyzable ketone analogue of AcCoA, dethiaAcCoA (AcMX) has
been used to study proton transfer because AcMX can only undergo the condensation
reaction. PCS•OAA catalyzes rapid HDX of methyl protons in AcMX or a methylene
proton in the poor substrate propionyl- CoA (Kurz et al., 1997). If AcMX enolization is
necessary and sufficient for CS•OAA- mediated HDX, the rate-limiting step could be
enolization (k-H) itself. However, the rate- limiting step could be the subsequent solvent
exchange of the buried, protonated Asp (kex) (Figure 1C). Protonation (kH) and
deuteration (kD) are less likely to be rate-limiting, given the instability of carbanion
intermediates (Thibblin and Jencks, 1979), and therefore less likely to be associated with
a detectable kinetic isotope effect (KIE).
Like PCS, the CS from the thermoacidophilic euryarchaeon Thermoplasma
acidophilum (TpCS) (Sutherland et al., 1990; Russell et al., 1994; Kurz et al, 2000) is a dimer
(type I), with one active site per subunit, each located at the subunit interface. The CS
from the Gram-negative bacterium Acetobacter aceti (AaCS) is a hexamer (type II CS)
comprising three protomers, each of which resembles the type I dimer.
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X-ray crystal structures of animal CS (Remington et al., 1982; Wiegand et al., 1984) and
diverse additional CS forms depict a high degree of conservation of overall structure and
within the active site, despite substantial sequence divergence. Crystal structures of CS
ternary

complexes

containing

OAA

and

the

AcCoA

enolate

analogue

carboxymethyldethia-coenzyme A (CMX) reveal virtually superimposable active sites in
type I chicken CS and type II AaCS (Usher et al., 1994; Francois et al., 2006). CS forms from
all three kingdoms of life appear to use the same chemical mechanism (Kurz, et al., 2000).
However, differences in the complete free energy profile for PCS and the partial free
energy profile for TpCS indicate that there are differences in on-enzyme equilibria and
kinetic barriers for these two most intensively studied CS forms (Kurz et al., 2009).
The purpose of this study is to examine the AaCS condensation reaction to test
the hypothesis that it is essentially the same as other CS forms.OAA strongly quenches
Trp fluorescence emission, in both type I TpCS and type II AaCS (Kurz et al., 2000; Francois
et al., 2006). Quenching is due to the polarized OAA carbonyl, which binds near TpCS
Trp348, and it is not observed in CS forms that lack this semiconserved Trp (Kurz et al.,
2005). In contrast, the addition of CitCoA transiently increases TpCS fluorescence
emission intensity (Kurz et al., 2005; Kurz et al., 2009). The condensation reaction can
therefore be monitored directly, as a proportional increase in intrinsic Trp fluorescence
reports directly on sp2 → sp3 conversion during carbon-carbon bond formation.
Similarly, the addition of AcMX to TpCS•OAA alleviates fluorescence quenching,
indicating it undergoes the condensation reaction forming dethiacitryl-CoA (CitMX) (Kurz
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et al., 2009). The formation of a stoichiometric TpCS•CitMX complex was confirmed by
an X-ray structure of crystals grown in the presence of OAA and AcMX (PDB entry 2r9e;
C. Lehmann and Z. Chen, unpublished observations). There is, however, no detectable
CitMX accumulation in solution, suggesting that CitMX is bound too tightly to TpCS to
dissociate. Furthermore, the extent of HDX in AcMX is superstoichiometric with respect
to enzyme concentration. For this to occur, CitMX must undergo the reversecondensation reaction to re-form OAA and AcMX (Figure 1D). In D2O, AcMX formed this
way can acquire one or more deuterium atoms in the terminal methyl group, depending
on whether HDX occurs only during the reverse condensation reaction (i.e., one
deuterium per CitMX formed) or may occur during carbanion formation (i.e., multiple
deuteria per binding event). HDX can either occur multiple times per AcMX binding event,
suggesting a processive mechanism of HDX during enolate formation, or HDX could occur
once per binding event, suggesting a distributive mechanism.
Stopped-flow fluorescence (SFF) studies of the conversion of TpCS•OAA+AcMX to
TpCS•CitMX were used to develop a kinetic model consistent with successive AcMX
binding and condensation steps (Kurz et al., 2009). This type of analysis was made possible
in TpCS because it happens to contain a reporter Trp (Kurz et al., 2000). Pre-steady-state
kinetic analysis on TpCS catalyzed condensation shows a primary deuterium KIE with
[methyl-d3] AcCoA (Kurz et al., 2009). This finding, together with the million-fold steadystate kinetic impairment of the TpCS-D317A mutant suggested that proton transfer(s) and
the Asp general base are involved in the rate-limiting step in the condensation reaction.
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Ordinarily, the subsequent hydrolysis reaction is rate-limiting in steady-state turnover by
TpCS (Kurz et al., 2000). Additional insight into this might be gleaned from presteady-state
studies of the stepwise deuteration of AcMX (Figure 1B). However, the ability of TpCS to
form CitMX introduces uncertainty about whether HDX occurs within the ternary complex
or during the reverse-condensation reaction that cleaves CitMX (Figure 1D).
In this work, we show that addition of AcMX does not affect OAA-mediated Trp
fluorescence quenching, indicating that a binary AaCS•CitMX complex either does not
form or does not accumulate to a substantial degree. AcMX nevertheless undergoes rapid
HDX catalyzed by AaCS•OAA. Progress curves monitoring the levels of isotopomer
intermediates formed during HDX are consistent with a distributive reaction
characterized by a single rate constant for all three exchange steps.
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Figure 4.1. Carbanion formation by ternary CS complexes and relationship to HDX of
AcCoA analogues. (A) AaCS residues interacting with a putative AcCoA enolate
intermediate (X = S and Y = CH2; R is the remainder of CoA), which undergoes reaction
with the highly polarized OAA carbonyl carbon during the condensation reaction.
Corresponding TpCS residue numbers are His222 and Asp317. Corresponding PCS residue
numbers are His274 and Asp375. AcMX (X = Y = CH2) is an AcCoA analogue. CMX (X = CH2;
Y = O) is an AcCoA enolate analogue. (B) Site exchange rate constants for CSOAA-catalyzed
AcCoA or AcMX methyl HDX (khdx) are subject to geometric selection effects of 3:2:1:0 for
isotopomers D0–D3. (C) HDX without condensation. Rate constants for proton
abstraction (k–H) and addition (kH), the corresponding deuterium rates (k–D and kD), and
solvent washout (kex) are assumed to have similar values for D0–D3. D1 can undergo
either proton abstraction (kH), which may result in D2 formation, or futile deuteron
abstraction (k–D). (D) HDX with condensation. CS OAA complexes that allow reversible
condensation of AcCoA or AcMX with OAA have the potential to take up a deuteron during
the reverse condensation reaction (k-cond) following solvent washout (k’ex), in addition to
the sequence illustrated in panel C (left hand sequence). Only AcCoA (X = S) is a substrate
for the subsequent hydrolysis reaction that forms citrate (khydr).
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4.2

Materials and Methods

Materials.
All chemicals were obtained from Sigma-Aldrich or Fisher in the highest grade
available and were used as received. AcMX and CMX were synthesized as previously
described (Francois et al., 2006). QuikChange mutagenesis kits were obtained from
Agilent (Santa Clara, CA).
Synthesis of AcCoA-h3 and AcCoA-d3.
AcCoA-d3, where the terminal methyl group is fully deuterated, was synthesized
as previously described (Gauthier et al., 2013). AcCoA-h3 was synthesized in parallel so
that it would contain the same contaminants present in AcCoA-d3. CoA (25 mg, 0.033
mmol) was dissolved in cold water (2 mL in a 15 mL conical tube). Either acetic anhydride
or d6-acetic anhydride (100 µL, 23 mmol) was added in 20 µL increments, with each
addition followed by immediate mixing and a 30 min incubation in an ice-water bath. The
pH was maintained near neutrality by the addition of saturated sodium bicarbonate and
monitored throughout the reaction by spotting small aliquots onto pH test strips
(Hydrion, New York). The progress of each reaction was monitored by removing aliquots
(5 µL) and quantifying any remaining unreacted CoA at 412 nm Δε = 14.1 mM-1 cm-1 after
reduction of the thiol reagent DTNB (Collier, 1973). When the CoA concentration was
steady for 30 min, the reaction was quenched by the addition of 98% formic acid (200 µL,
5.3 mmol). Each reaction mixture was lyophilized to dryness. Solids were re-suspended in
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5 mM (5 mL) HCl, centrifuged at 16,000 g for 10 min, and the full volume was injected
onto an Agilent 110 series HPLC equipped with a Luna 5 µm C18(2) 250 × 21.2 mm column
(Phenomenex; Torrance, CA) equilibrated in water containing 0.1% (v/v) trifluoroacetic
acid (TFA) and 2.0% (v/v) methanol. The column was developed in a linear gradient of 2%
to 90% methanol in 0.1% TFA with absorbance monitoring at 260 nm. The peak
corresponding to AcCoA was collected, frozen, lyophilized to dryness, and resuspended
in 5 mM HCl (0.1 mL).
Synthesis of AcMX-d3.
AcMX (250 nmol) was incubated in 250 µL deuterated SCACT buffer (50 mM potassium
phosphate, pD = 8.0, 100 mM KCl in 99.9 % D2O (Cambridge isotope labs, Andover, MA))
containing 0.6 mM OAA (from a 10 mM stock prepared in 1× deuterated SCACT buffer),
and 4 µM TpCS (from a concentrated stock prepared in 1× deuterated SCACT buffer) at
22 °C in a 1.5 mL microfuge tube. After 15 h, the reaction was quenched by the addition
of 98% formic acid (30 µL, 0.8 mmol) and solids, including denatured enzyme, were
removed by centrifugation at 16,000 g for 10 min in microfuge tubes. The reaction
mixture was applied to a C18 Sep Pak (Waters) cartridge that had been washed with
methanol (10 mL) and then washed and equilibrated in 0.1% formic acid (10 mL). The
cartridge was washed with 0.1% formic acid (10 mL) and the sample was eluted with
methanol (3 mL). The sample was dried using a vacuum concentrator (Eppendorf;
Hauppauge, New York) and resuspended in 5 mM HCl (0.1 mL).
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General analytical methods.
Protein masses were determined by electrospray-ionization mass spectrometry
(ESI-MS) by the staff of the Washington University Mass Spectrometry Resource.
Absorbance measurements were recorded using a Varian Cary 100 Bio UV-visible
spectrophotometer thermostated at 25 °C. 1H NMR spectra were obtained at 500 MHz
using a Varian Unity Inova 500 spectrometer equipped with a 5 mm Varian reverse probe.
The pL (pH or pD) was determined using a glass electrode. pD was calculated by adding
0.4 to the displayed pH value. (Lumry et al., 1951). All curve fitting was performed using
gnuplot 4.4, Origin 8.6 (OriginLab; Northampton, MA), or DynaFit (Kuzmic, 1996).
Protein expression, purification, and analysis.
Plasmids pJK136 and pJK225 encode AaCS and AaCS with the octapeptide
LEHHHHHH appended to the C-terminus (AaCSH6), respectively (Francois et al., 2006).
QuikChange mutagenesis of pJK225 with oligodeoxynucleotides 898 and 899 (sequences
given in Supporting information, Table S1) furnished plasmid pJK241 (AaCSH6-W404F).
QuikChange mutagenesis of pJK225 with oligodeoxynucleotides 959 and 960 furnished
plasmid pJK708 (AaCSH6-W400F).
AaCSdye, a wild-type AaCS isolated by dye-ligand affinity, and AaCSH6 were
produced as described (Francois et al., 2006). AaCSH6 mutants were overproduced in
BL21(DE3) cells transformed with a suitable plasmid and purified using the procedure
reported for AaCSH6. Protein concentrations were measured using the Bradford assay
(Bio-Rad) with bovine serum albumin used as the standard (Bradford, 1976).
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Inhibition patterns and constants were determined using AaCSdye and assay
method B (Francois et al., 2006), modified to use a fixed concentration of 0.1 mM OAA
(AcCoA varied from ≤9 to ≥143 µM) and by the addition of candidate inhibitors.
Kinetic methods and substrate concentrations.
Concentrations of AcCoA and AcMX were determined spectrophotometrically
assuming an extinction coefficient of 16.4 mM-1 cm-1 at 260 nm (Dawson, 1993). Citrate
synthase activity in H2O and D2O with AcCoA-h3 or AcCoA-d3 was determined in reaction
mixtures (final volume 0.7 mL) containing 50 mM potassium phosphate pL = 8.0, 100 mM
potassium chloride, 400 µM OAA, 300 µM DTNB, varied AcCoA-h3 or AcCoA-d3, and
either AaCSH6 (0.076 µg, 0.017 units) or TpCSH6 (0.55 µg, 0.007 units) added last to
initiate the reaction (Srere, 1969). A unit is defined as the amount of enzyme required
to produce 1 µmol of product per min.
Fluorescence measurements.
Fluorescence measurements were recorded at 25 °C using a Cary Eclipse
fluorescence spectrophotometer (Agilent; Santa Clara, CA) or a Fluoromax-3 (Horiba Jobin
Yvon; Edison, NJ) (slit widths of 5 nm, except where noted) with continuous stirring.
Fluorescence emission spectra were corrected for dilution and for inner filter effects using
N-acetyltryptophanamide.
AaCS attached to a C-terminal fluorescein (Fl) tag (AaCSFl) was prepared by
expressed protein ligation (Supporting Information). The mole fraction of AaCS labelled
with fluorescein (Fl), PFl, was determined by a modified literature method using
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Equation1. The AaCS extinction coefficient (ε280 = 49,740 M-1 cm-1) measured in buffer
PK9 (50 mM potassium phosphate, pH 9.0, 100 mM KCl) was comparable to a value
(44,760 M-1 cm-1) computed assuming reduced cysteines (Gill and von Hippel, 1989).
The Fl extinction coefficient εFl at pH 9 was 74,000 M-1 cm-1 (Molecular Probes, Inc).

[𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴]

𝑃𝑃𝐹𝐹𝐹𝐹 = [𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴]+[𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴] =

𝐴𝐴494
𝐹𝐹𝐹𝐹
𝜀𝜀494

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴
𝜀𝜀280

(4.1)

𝐴𝐴280 −𝑘𝑘𝑘𝑘494

Förster resonance energy transfer (FRET) efficiency (E) was computed using
Equation 2, where fAaCS and fAaCSFl represent the fluorescence of a 1 M solution of AaCS or
AaCSFl, respectively.
𝐸𝐸 = 1 −

𝐼𝐼𝐷𝐷𝐷𝐷
𝐼𝐼𝐷𝐷

𝑓𝑓𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 −𝑓𝑓𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (1−𝑃𝑃𝐹𝐹𝐹𝐹

=1−[

𝑃𝑃𝐹𝐹𝐹𝐹 𝑓𝑓𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴

]

(4.2)
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Using the Förster radius (R0) of 27 Å for Trp (donor) and fluorescein (acceptor) (Gill
and von Hippel, 1989), the average donor-acceptor distance (𝑟𝑟̅𝐷𝐷𝐷𝐷 ) was computed using

Equation 3 (Griep and McHenry, 1990).
1

𝑟𝑟̅𝐷𝐷𝐷𝐷 = 𝑅𝑅0 � − 1
𝐸𝐸

(4.3)

Stopped-flow fluorescence spectroscopy.
Transient kinetic experiments were performed on either a SX.18-MV stopped-flow
(SF) apparatus (Applied Photophysics, Leatherhead, U.K.) with a cutoff filter (> 305 nm)
and an instrumental dead time of 1.2 ms or a SF-61 DX2 SF apparatus (Hi-Tech; TgK,
Bradford-on-Avon, UK) with a cutoff filter >320 nm and an instrumental dead time of 2
ms. Intrinsic protein fluorescence was excited at 296 nm. OAA binding interactions were
initiated at 25 °C by mixing equal volumes of AaCS + varied OAA concentration. AcMX
binding interactions were initiated at 25° by mixing equal volumes of AaCS•OAA
(equilibrated in either H2O or D2O) and either AcMX or AcMX-d3 in H2O or D2O,
respectively. For AcMX or AcMX-d3 binding interactions each syringe contained the same
concentration of OAA. Parallel control experiments lacking enzyme or ligands were also
performed. The instantaneous post-mixing reaction mixture contained 50 mM potassium
phosphate, pL = 8, 100 mM KCl, 0.1 or 0.2 mM OAA, 1 or 5 µM AaCSH6, variable AcMX/
AcMX-d3, or AcCoA-h3/AcCoA-d3. Rate constants were obtained by fitting progress
curves to Equation 4.4.
𝐹𝐹(𝑡𝑡) = 𝐹𝐹∞ + 𝐹𝐹0 (1 − 𝑒𝑒 −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑡𝑡 )

(4.4)
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(4.5)

A reversible two-step binding model with E = AaCS•OAA and L = AcMX (Equation
4.5) is expected to show a hyperbolic dependence of the observed rate (kobs) on [L]
(Equation 4.6)

𝑘𝑘 [𝐿𝐿]

2
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 = [𝐿𝐿]+𝐾𝐾

𝑑𝑑1

+ 𝑘𝑘−2

(4.6)

NMR spectroscopy.
HDX was monitored by NMR recorded at 500 MHz as described (Kurz et al., 1997),
except that spectra were acquired every 8.4 min. The reaction mixture contained 20.5 nM
AaCS (subunit concentration), 1.0 mM OAA, 0.987 mM AcMX, and 50 mM potassium
phosphate, pD 7.9 at 25 °C. Peak areas recorded at different times, I(t), were subjected to
baseline correction and referenced to the peak area (corrected for dilution) measured
prior to the addition of enzyme, I0. The observed HDX rate kobs was determined by a fit of
the data to Equation 7. The relative final peak area, I∞/I0, was set to 19% to account for
any unreactive fraction and the background due to baseline integration.
𝐼𝐼(𝑡𝑡)
𝐼𝐼0

= (1 − 𝐼𝐼∞ )𝑒𝑒 −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 𝑡𝑡 + 𝐼𝐼∞

𝑘𝑘𝐻𝐻𝐻𝐻𝐻𝐻 = 3

[𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴]
𝑘𝑘
[𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴•OAA] 𝑜𝑜𝑜𝑜𝑜𝑜

(4.7)

(4.8)
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The kobs value was converted to a specific rate using Equation 4.8 as previously described
(Kurz et al., 1997).
NMR spectra of AcMX were examined for evidence of nonenzymatic HDX using
data recorded in the same solution conditions without enzyme. A peak with δ = 8.55 ppm
and T1 = 1.91 s (in H2O), assigned to the adenine H8 proton, was observed to decrease in
intensity over 2900 min with a linear slope of (-7.09 ± 0.09) × 10-5 min-1. A peak with δ =
8.51 ppm appeared at the same rate. A peak with δ = 0.73 ppm and T1 = 0.48 s (in H2O),
assigned to a pantoate methyl group, appeared to exchange for one with δ = 0.77 ppm,
each with a linear slope of |5.09 ± 0.03| × 10-5 min-1.
Mass spectrometry.
CS-mediated AcMX HDX reactions were monitored by ESI-MS performed in
positive ion mode on a Finnegan LCQ Classic with sheath gas flow rate 20, auxiliary gas
flow rate 5, spray voltage 4 keV, capillary temperature 200 °C, capillary voltage 45 V, and
tube lens offset 10 V. The sample was directly infused at 5 µL min-1 using a syringe pump.
An exchange reaction equilibrated at 23 °C contained (final volume of 0.76 mL) 50 mM
ammonium formate, pD 7.9, 1 mM OAA, 0.9 mM AcMX, and 20 nM AaCS. HDX was
initiated by the addition of enzyme. At intervals ranging from 5–10 min, an aliquot (1 µL)
was diluted into quench solution (249 µL of 50% acetonitrile in water adjusted to pH 2.5
with formic acid), vortexed briefly, and then directly infused for 5 min of data
accumulation. The data were acquired in zoom scan mode centered at m/z 795 with a 10
amu window. Scans were summed and peaks were picked using a homebuilt algorithm
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(D. Rempel, unpublished program). Picked peak intensities were corrected for isotopic
abundances in the AcMX stock solution in D2O. This correction was necessary due to slow
exchange of a single proton within the adenosine nucleotide. The mole fraction (χ) of each
AcMX terminal methyl isotopomer (D0 – D3) was obtained by normalizing each peak area
to the sum of corrected peak areas at M, M+1, M+2, and M+3.
Analysis of exchange kinetics.
HDX in the terminal methyl group of AcMX was modeled as a sequence of three
sequential, irreversible, first-order reactions (Figure 4.1) described by four differential
equations (Equations 4.9-12).

∂𝐷𝐷0
χ
∂𝑡𝑡

= −𝑘𝑘𝑎𝑎 χ𝐷𝐷0 𝑡𝑡

(4.9)

∂𝑡𝑡

= 𝑘𝑘𝑎𝑎 χ𝐷𝐷0 𝑡𝑡 − 𝑘𝑘𝑏𝑏 χ𝐷𝐷1 𝑡𝑡

(4.10)

∂𝑡𝑡

= 𝑘𝑘𝑏𝑏 χ𝐷𝐷1 𝑡𝑡 − 𝑘𝑘𝑐𝑐 χ𝐷𝐷2 𝑡𝑡

(4.11)

∂𝑡𝑡

= 𝑘𝑘𝑐𝑐 χ𝐷𝐷2 𝑡𝑡

(4.12)

∂𝐷𝐷1
χ
∂𝐷𝐷2
χ
∂𝐷𝐷3
χ

An integrated rate expression was obtained for each isotopomer using the

boundary condition 𝝌𝝌0D0 = 1 (Equations 4.13-16).
χ𝐷𝐷0 = 𝑒𝑒 −𝑘𝑘𝑎𝑎 𝑡𝑡
χ𝐷𝐷1 =

𝑘𝑘𝑎𝑎

𝑘𝑘𝑏𝑏 −𝑘𝑘𝑎𝑎

[𝑒𝑒 −𝑘𝑘𝑎𝑎 𝑡𝑡 − 𝑒𝑒 −𝑘𝑘𝑏𝑏𝑡𝑡 ]

χ𝐷𝐷2 = 𝑘𝑘𝑎𝑎 𝑘𝑘𝑏𝑏 [(𝑘𝑘

𝑒𝑒 −𝑘𝑘𝑎𝑎 𝑡𝑡
𝑎𝑎 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑏𝑏 )

− (𝑘𝑘

(4.13)
(4.14)

𝑒𝑒 −𝑘𝑘𝑏𝑏 𝑡𝑡
𝑏𝑏 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑏𝑏 )

+ (𝑘𝑘

𝑒𝑒 −𝑘𝑘𝑐𝑐 𝑡𝑡
]
𝑏𝑏 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑐𝑐 )

(4.15)

122

χ𝐷𝐷3 = [1 − (𝑘𝑘

𝑘𝑘𝑏𝑏 𝑘𝑘𝑐𝑐 𝑒𝑒 −𝑘𝑘𝑎𝑎𝑡𝑡
𝑎𝑎 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑏𝑏 )

+ (𝑘𝑘

𝑘𝑘𝑎𝑎 𝑘𝑘𝑐𝑐 𝑒𝑒 −𝑘𝑘𝑏𝑏 𝑡𝑡
𝑏𝑏 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑏𝑏 )

+ (𝑘𝑘

𝑘𝑘𝑎𝑎 𝑘𝑘𝑏𝑏 𝑒𝑒 −𝑘𝑘𝑐𝑐 𝑡𝑡
]
𝑏𝑏 −𝑘𝑘𝑐𝑐 )(𝑘𝑘𝑎𝑎 −𝑘𝑘𝑐𝑐 )

(4.16)

Equation 13 was modified to account for the contribution of a molecule that is

isobaric with D0, χ𝐷𝐷0
∞ , but does not undergo reaction during the experiment (Equation

4.17).

χ𝐷𝐷0 = 𝑒𝑒 −𝑘𝑘𝑎𝑎 𝑡𝑡 + χ𝐷𝐷0
∞

(4.17)

If the observed rate of HDX is the same for all three HDX reactions, subject only

to a geometric factor that scales the observed rate constant to the average rate
constant for the removal of a proton (i.e, 𝑘𝑘𝑎𝑎 = 3𝑘𝑘𝑐𝑐̅ , 𝑘𝑘𝑏𝑏 = 2𝑘𝑘𝑐𝑐̅ , 𝑘𝑘𝑐𝑐 = 𝑘𝑘𝑐𝑐̅ ), the integrated
rate expressions simplify to Equations 18-21.
χ𝐷𝐷0 = 𝑒𝑒 −3𝑘𝑘𝑐𝑐� 𝑡𝑡 + χ𝐷𝐷0
∞

(4.18)

χ𝐷𝐷2 = 3𝑒𝑒 −𝑘𝑘𝑐𝑐� 𝑡𝑡 − 6𝑒𝑒 −2𝑘𝑘𝑐𝑐� 𝑡𝑡 + 3𝑒𝑒 −3𝑘𝑘𝑐𝑐� 𝑡𝑡

(4.20)

χ𝐷𝐷1 = 3𝑒𝑒 −2𝑘𝑘𝑐𝑐� 𝑡𝑡 − 3𝑒𝑒 −3𝑘𝑘𝑐𝑐� 𝑡𝑡

(4.19)

χ𝐷𝐷3 = 1 − 3𝑒𝑒 −𝑘𝑘𝑐𝑐� 𝑡𝑡 − 3𝑒𝑒 −2𝑘𝑘𝑐𝑐� 𝑡𝑡 + 𝑒𝑒 −3𝑘𝑘𝑐𝑐� 𝑡𝑡

(4.21)

HDX progress curves were fit globally to both sets of four integrated rate
expressions.
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4.3

Results

OAA primarily quenches AaCS Trp400 fluorescence.
The addition of OAA strongly quenches TpCS fluorescence (Kurz et al., 2000). TpCS
Trp348, a buried and immobile residue that is about 9 Å from the OAA carbonyl, is the
primary fluorescence emitter and is most sensitive to OAA binding (Kurz et al., 2005).
AaCS fluorescence is similarly quenched by OAA, albeit to a lesser degree (Francois et al.,
2006). Of the four present in AaCS and TpCS, only one (AaCS Trp400) is conserved in both.
AaCS Trp400 adopts the same orientation, relative to OAA, as TpCS Trp348 (Figure 2). A
second Trp, AaCS Trp404, is farther from OAA than Trp400 but is nearly equidistant to
two OAA binding sites and might therefore undergo enhanced quenching by OAA.
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Figure 4.2. Structure of AaCS•OAA•CMX (PDB entry 2H12). (A) AaCS hexamer surface. The
view is along the pseudo-twofold axis (center) that relates the subunits in each dimeric
protomer (subunit A, light brown; subunit B, cyan). A perpendicular pseudo-threefold axis
(blue rod with triangular symbol, shown in the plane of the page) defines the hexameric
assembly. The hexameric interface is much smaller than the extensive dimeric interface
(Nguyen et al., 2001). Red spheres indicate the locations of the C-terminal residue
(Arg436) in four subunits; the last 15 residues in each subunit are draped over the Nterminal domain of the partner subunit. Part of the AcCoA analogue CMX (stick rendering)
is visible in both active sites of the AB protomer. (B) Walleyed stereodiagram depicting
the interior of the AaCS dimer. The interior of the protein is light gray; the exterior
surfaces have the same colors as panel A. Active site ligands are shown in ball-and-istick
rendering; CMX is truncated at the equivalent of CoA C600 PMID 9047322. The Trp
residues are shown in stick rendering with carbon atoms colored by subunit. Dotted lines
are labeled with the distance (in Å, for separations ≤ 20 Å) between each OAA carbonyl
carbon and the closest indole carbon or nitrogen atom; intrasubunit contacts are yellow
(chain A) or salmon (chain B) and intersubunit contacts are purple. The closest contact to
Trp268 Cg is slightly shorter than the illustrated contact to Cd 1 (14.7 Å and 14.8 Å,
respectively), but would have been obscured behind the purple dotted line. Trp182 is 27
Å from OAA carbonyls in the same protomer, but is the closest to an OAA carbonyl in an
adjacent protomer (37 Å). Dotted lines and ligand models extend beyond the near clipping
plane used to generate the interior section.
To assess the relative contribution of each Trp to fluorescence emission spectra,
and ligand-dependent changes in those spectra, AaCS forms lacking either Trp400 or
Trp404 were isolated by the method developed for AaCSH6 and found to retain
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substantial enzymatic activity (Table 4.1). The mutant containing Trp400, AaCSH6W404F, was analyzed by ESI-MS.
Two main forms were observed, one with m/z 49018 (49020.3 expected for [MMet+H]) and one with m/z 48958 (48960.3 expected for [M-Met- Gdn+H]). The second
peak is proposed to be due to gas-phase loss of a guanidinium group, as previously
observed with AaCS forms (Francois et al., 2006).
Table 4.1. Selected kinetic and binding constants for AaCS forms.
parameter

AaCSH6

AaCSH6-W404F

AaCSH6-W400F

AaCSFl

k (s )

95

66

65

78

(µM)

29

31.7

87

52

19.6

NA

ND

ND

-1

cat

K

AcCoA

M

K

OAA

(µM)

14.2

K

AcMX

(µM)

6.7

d

d

d

b

e

c

e

25
5.1 /
8.2
f

g

Data from Ref 17
Previously reported to be 21 µM (17).
c
NA, not applicable. No protein fluorescence change was noted upon the addition
of OAA (Figure 3C). An earlier experiment with AaCSH5-W400F, i.e., a mutant
lacking one residue in the affinity tag, gave a fluorescence decrease associated
with an OAA Kd = 180 µM (data not shown).
d Based on a titration with AcMX-d3 in D O-containing buffer.
2
e
ND, not done. fultraviolet gvisible
a

b

The fluorescence emission spectrum of AaCSH6-W404F was quenched by the
addition of OAA, to an extent similar to AaCSH6 (Figure 3B). In contrast, AaCSH6-W400F
showed no quenching by OAA (Figure 3C). This indicates that AaCS Trp400 fluorescence
is the only one sensitive to OAA binding. Trp404 may, however, contribute more than
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Trp400 to the basal fluorescence emission intensity of AaCS. The OAA binding affinities
for AaCS and AaCS W404F were determined by fluorescence titration. The data were fit
to a simple hyperbolic isotherm (Figure 3D) with binding affinities listed in Table 4.1.

Figure 4.3. Effect of OAA on AaCS fluorescence emission. In panels A–C, the solid
line is the fluorescence emission spectra of unbound AaCS or single Trp mutants
and the dashed line is recorded in the presence of 100 µM OAA. (A) AaCSH6. (B)
AaCSH6-W404F (contains Trp400). (C) AaCSH5-W400F (contains Trp404). (D) OAA
titrations of AaCSH6, filled circles fit is solid black line; AaCSH6-W404F, open
circles fit is dashed line. OAA binding affinities from these data are listed in Table
4.1.
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A preliminary stopped-flow fluorescence (SFF) study of AaCS (0.4 µM subunit
concentration, post-mixing) binding to OAA (4–100 µM) at 25 °C and pH 8 showed very
fast fluorescence changes, with every observed rate kobs >650 s-1 (data not shown). OAA
binding to AaCS forms appears to be very rapid.
Competitive inhibition of AaCS•OAA by AcCoA analogues.
AcCoA or AcCoA enolate analogues CoA, AcMX, carboxymethyl-coenzyme A
(CMCoA), and CMX are progressively potent, competitive inhibitors of PCS (Bayer et al.,
1981; Martin et al., 1994)). These compounds are progressively potent, reversible
inhibitors of AaCS and all are competitive with respect to AcCoA (Figure 4.4). PCS has
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴
𝐾𝐾𝑖𝑖𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 ≈𝐾𝐾𝑚𝑚
(Martin et a., 1994). AcMX was a more potent inhibitor of AaCS in both
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴
absolute and relative terms: 𝐾𝐾𝑖𝑖𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 was ten times smaller than 𝐾𝐾𝑚𝑚
(table 4.2).
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Table 4.2: Inhibition of AaCS by AcCoA analogues.
Ki (µM)
Inhibitor

AcCoA varieda

OAA variedb

CoA

31 ± 3

~120

AcMX

2.8 ± 0.2

~130

CMCoAc

0.30 ± 0.04

NDd

CMX

0.047 ± 0.007

NDd

Competitive inhibition pattern (Figure 4). Determined at pH 8.0 and 25 °C with
25 mM OAA (5 × KM).
b
Uncompetitive inhibition pattern (data not shown). Determined at pH 8.0 and
25 °C with 150 mM AcCoA (5 × KM).
c
A slight time-dependence of inhibition was noted (Charles Z. Constantine, data
not shown). The true Ki may be smaller than the stated value.
d
ND, not determined.
a
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Figure 4.4. Competitive inhibition of AaCS. The line shown at each inhibitor concentration
was computed from parameters obtained from a global fit of data obtained at all inhibitor
concentrations to a competitive inhibition model. While the fitting was performed using
concentration and velocity values, it is shown as a Lineweaver-Burk plot to highlight
agreement of the model to the transformed data points. (A) CoA inhibition. The symbols
indicate velocity data collected at 0 (filled circles), 10 (open circles), 30 (filled triangles),
or 50 µM inhibitor (open triangles). (B) AcMX inhibition. The symbols indicate velocity
data collected at 0 (filled circles), 1.55 (open circles), 3.1 (filled triangles), or 4.65 µM
inhibitor (open triangles). (C) CMCoA inhibition. The symbols indicate velocity data
collected at 0 (filled circles), 0.278 (open circles), 0.83 (filled triangles), or 1.4 µM inhibitor
(open triangles). (D) CMX inhibition. The symbols indicate velocity data collected at 0
(filled circles), 0.05 (open circles), 0.1 (filled triangles), or 0.2 µM inhibitor (open triangles).
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AaCS•OAA binds AcMX without condensation: fluorescence titrations.
The addition of AcMX to TpCS•OAA eliminates most of the fluorescence
quenching due to OAA (18) . AcMX is the only AcCoA analogue associated with this
“dequenching” phenomenon: formation converts the OAA carbonyl carbon to a nonquenching sp3 center (Kurz et al., 2009). In contrast, the addition of AcMX had little effect
on fluorescence emission spectra (Figure 4.5, crosses). Since OAA appears to quench
AaCS fluorescence by the same mechanism as TpCS fluorescence, AcMX is not converted
to CitMX by AaCS•OAA. However, addition of deuterated AcMX (AcMX-d3) to AaCS•OAA
in D2O does cause a decrease in fluorescence that appears to saturate. The data were fit
to a simple hyperbolic binding isotherm with a Kd value of 6.7 ± 1.5 µM (Figure 4.6 and
table 4.1) which is in good agreement with the AaCSFl binding studies (Figure 4.5).
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Figure 4.5. Fluorescence detection of AcMX binding to AaCSFl•OAA. All points are derived
from fluorescence emission intensities recorded in 50 mM potassium phosphate, pH 8,
100 mM KCl, and 120 µM OAA at 25 °C after 3 min of equilibration at the indicated [AcMX].
Spectra have been corrected for dilution and inner filter effects due to OAA. Crosses,
ultraviolet titration of AaCS•OAA (1 mM subunits; excitation: 296 nm; emission: 346 nm).
The small fluorescence changes were not fit to a binding isotherm. Open circles,
ultraviolet titration of AaCSFl•OAA (1.18 µM subunits; excitation: 295 nm; emission: 346
nm). Dotted line, fit of the fluorescence decrease to Equation 4 (fitted parameters given
are in Table 4.1). Filled circles, visible titration of AaCSFl•OAA (0.7484 mM subunits;
excitation: 498 nm; emission: 524 nm). Solid line, fit of the fluorescence decrease to
Equation 4 (fitted parameters are given in Table 4.1).
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Figure 4.6. Detection of AcMX-d3 binding to AaCS•OAA in D2O.All points are derived from
fluorescence emission intensities recorded in 50 mM potassium phosphate, pH 8, 100 mM
KCl, and 100 µM OAA at 25 °C after 3 min of equilibration at the indicated [AcMX]. Spectra
have been corrected for dilution and inner filter effects due to OAA.
To facilitate studies of AcMX binding to AaCS•OAA in H2O, expressed protein
ligation (Appendix) was used to fuse a dipeptide containing the fluorescent reporter
group 6-carboxyfluorescein (Fl-tag) to the C-terminus of AaCS (AaCSFl). AaCS and AaCSFl
had similar enzymatic activity (Table 4.1), OAA affinity (Table 4.1, Figure A1), and
indistinguishable mobility on SDS-PAGE gels (not shown). FRET efficiencies of various
AaCSFl complexes were determined (Table A2). ESI-MS indicated an approximately 1:1
ratio of AaCS (observed m/z 47932; 47933.2 expected) to AaCSFl (observed m/z 48436;
48436.7 expected). Absorbance spectra (Figure A2) were used to compute PFl = 0.55
± 0.02, where the standard deviation is based on five replicate preparations. These data
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were consistent with an average composition of three Fl per AaCS hexamer, or about one
Fl per AaCS protomer.
The addition of AcMX to AaCSFl•OAA in H2O led to a progressive decrease in
fluorescence emission, with either ultraviolet or visible excitation (Figure 4.5B and 4.5C).
Titration data were fit by a simple hyperbolic binding isotherm (Table 4.1). Neither
transition corresponds to dequenching, since the change in the ultraviolet region has the
opposite sign and controls demonstrate that the visible fluorophore would not be
effectively quenched by OAA. The fluorescence decreases can be attributed to changes in
the fluorophore environment that are induced by AcMX binding, most likely as a
consequence of Fl-tag interacting with the partner subunit. AaCS conformational changes
observed by peptide HDX are consistent with this interpretation (S. A. Kerfoot,
unpublished observations).
AcMX HDX catalyzed by AaCS•OAA: NMR analysis.
Binding of AcMX to AaCS•OAA does not induce the “dequenching” phenomenon
observed in TpCS suggesting condensation does not occur to a significant extent. A direct
test for AcMX enolization by AaCS•OAA is the observation of HDX in the terminal methyl
groups. To prepare for this experiment, the rate of AcCoA dependent turnover in D2O was
determined: kcat = 102 s-1 at pD 7.9 appears to have a slightly larger solvent isotope effect
(D2Okcat = 1.3 at pL= 8.0) than other CS forms.
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H NMR was then used to monitor HDX as a decrease in the area of the signal

1

corresponding to the terminal methyl protons. A single-exponential fit gave an average
rate constant kHDX = 18.8 ± 0.2 s-1 (Figure 4.7). AaCS•OAA catalyzes AcMX HDX, albeit at
a substantially lower rate than steady-state AcCoA turnover under the same conditions.

Figure 4.7. AcMX HDX progress curve monitored by 1H NMR at 25 °C. The solid line is
a single exponential fit to the data with an observed decay rate v = (7.84 ± 0.08) x 103
min-1.
NMR analysis shows convergence to a nonzero value (I∞) that is due to an
unreactive fraction with the same methyl chemical shift (D0∞), as well as the background
due to baseline integration. HPLC analysis of AcMX shows two peaks, with a 5:1 area ratio
(Figure A3). These correspond to AcMX and iso-AcMX, respectively, where iso-AcMX is
the 2’-phospho isomer of AcMX (Burns et al., 2005). The unreactive fraction D0∞ may be
iso-AcMX, which would suggest it is not accepted by AaCS•OAA as an HDX substrate.
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AcMX HDX catalyzed by AaCS•OAA: ESI-MS analysis.
ESI-MS allowed
∞ quantitation of individual AcMX isotopomers (Figure 4.8) and the
construction of a progress curve for HDX at saturating levels of AcMX (Figure 4.9).
Sequential formation of each isotopomer was observed, consistent with a distributive
HDX model. A small amount of a species with the same mass as D0 was not accepted by
as an HDX substrate during the period examined. As with the NMR experiments, this
unreactive species (D0∞) was presumed to be iso-AcMX. The mole fraction of the
unreactive species (χ

) was fixed at 9% during global fits of progress curves.

D0

Figure 4.8. AcMX HDX monitored by ESI-MS. The blue lines are experimental spectra
recorded after the indicated HDX period. The red symbols in each panel indicate the
expected locations and relative peak heights for AcMX at natural isotopic abundance
(C24H40N7O17P3: expect peaks at m/z 790.2 – 795.2 with relative abundances of 100%,
29.7%, 7.7%, 1.4%, and 0.2%).

136

Figure 4.9. AcMX HDX progress curve monitored by ESI-MS. The dotted lines are global
fits to the mole fraction of each isotopomer with three independent observed velocities
va = 0.043 ± 0.019 min-1, vb = 0.020 ± 0.008 min-1, and vc = 0.012 ± 0.008 min-1. The solid
lines represent a global fit using an average site exchange rate (𝑣𝑣𝑐𝑐̅ = 0.012 ± 0.002 min1
), assuming a geometric selection factor and isotope effects equal to unity. (The
unreactivemole fraction χ𝐷𝐷0
∞ was fixed at 0.9 for both fits. The data points for
χ𝐷𝐷0 incorporate this contribution).

A previously reported kinetic model for methyl group HDX (Pratt, 1977)) that

accounts for both processive and distributive processes was simplified to a distributive
model of three sequential, irreversible HDX steps with three independent rate constants
(Equations 4.14-17). A global fit of all four isotopomer progress curves to this model (Figure
4.9, dotted lines) furnished three velocities (va, vb, vc). in an approximate 3:2:1 ratio. These
results indicate that geometric selection effects are sufficient to account for the relative
rate of formation of each isotopomer.
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A second, simpler HDX model incorporating a single velocity parameter (𝑣𝑣𝑐𝑐̅ ),

geometric selection, and isotope effects of unity (Equations 4.18-21) also gave a good

global fit to all four progress curves (Figure 4.9, solid lines). This fit furnishes 𝑘𝑘𝑐𝑐̅ , the rate
constant for exchange of a single methyl proton, and kHDX, the AcMX methyl HDX rate
constant, where kHDX = 3 × 𝑘𝑘𝑐𝑐̅ = 27 ± 5 s-1.
Binding of AcMX to AaCS•OAA: stopped-flow fluorescence analysis.
A small or undetectable equilibrium fluorescence change can be a consequence of
presteady-state fluorescence changes in opposite directions. The ligand AcMX-d3 was
chosen for this analysis because the steady-state titration in D2O, which excludes the
possibility of time dependent changes due to HDX, resulted in a larger fluorescence
change than the protonated ligand. To detect transient fluorescence changes in
AaCS•OAA, it was rapidly mixed with varied concentrations of either AcMX in normal
aqueous buffer or AcMX-d3 in D2O-containing buffers. All fluorescence changes were
completed within 20 ms. A very small decrease in fluorescence occurred during the
instrument dead time, followed by a monophasic increase in fluorescence emission
intensity (Figure 10). Each progress curve was fit to a single exponential equation. These
data were analyzed to determine the concentration dependence of the observed rate
(kobs) and amplitudes of the fluorescence change.
The maximal amplitude of the fluorescence change appears to saturate at high
AcMX-d3 concentrations and was fit to a simple hyperbolic isotherm with an apparent
binding affinity, consistent with a Kd, of 12 ± 2 µM (Figure 4.11). This apparent binding
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affinity is slightly higher than the Kds calculated from steady-state titrations (Table 4.1).
The observed rate either shows no concentration dependence or is too fast to observe
quantitatively given the small signal change (Figure 4.11, inset). Rapid mixing of AcMX
with AaCS•OAA in H2O and D2O resulted in similar data with lower signal to noise. These
data are consistent with rapid equilibrium binding that has a fluorescence change too
small to observe.
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Figure 4.10. SFF analysis of AcMX binding to AaCS•OAA (H2O buffer). A, A progress curves
recorded at final concentrations of 1 μM AaCS, 100 μM OAA, and 20 μM AcMX at 25 °C.
Experimental data (symbols) were fit to a single exponential function (solid red line) to
obtain observed rate kobs = 280 ± 6 s-1. The bottom panel shows fitting residuals. B, kobs as
a function of [AcMX]. The range of values obtained is 220–345 s-1 (average 284 s-1). The
scatter of the kobs data is too great to allow reliable fitting to a hyperbolic function but it
seems likely that the ordinate axis intercept (e.g., koff) is nonzero.
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Figure 4.11. Amplitude of the fluorescence increase observed in SFF experiments mixing
AaCS•OAA (pre-exchanged) with AcMX-d3 in D2O. Variable concentrations of AcMX-d3
was ra pidly mixed with 10 µM AaCS (subunit) pre-equilibrated with 200 µM OAA in 50
mM potassium phosphate pD = 8.0, 100 mM KCl at 25 °C. Each data set was fit to a single
exponential to determine the amplitude of the fluorescence change and the observed
rate constant. The amplitude term appears to saturate at high AcMX-d3 concentrations
with a maximum fluorescence increase of 14% at high [AcMX-d3]. Inset, concentration
dependence of kobs. No concentration dependence on the observed rate constants was
observed.
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AaCS•OAA + AcCoA-h3 single turnover reactions: stopped-flow fluorescence analysis.
Preliminary AaCS•OAA + AcCoA-h3 single turnover reactions were performed.
Unbound AaCS was arbitrarily set to 100%, where buffer alone is 0%, fluorescence and
saturating OAA quenched AaCS fluorescence by 21.5% (78.5% remaining fluorescence).
The reaction of AcCoA-h3 with excess AaCS•OAA shows a rapid 11% rise in fluorescence
during the instrument dead time (~ 2.0 ms). This was followed by a transient fluorescence
rise that never returns to the OAA quenched baseline (representative data shown in
Figure 12). The cause of the fast initial rise is unclear and not observed in TpCS•OAA (Kurz
et al., 2009). These data were fit to a double exponential function (Eqn 4.22) with values
for the fitted parameters given in Table 4.3.
𝑌𝑌 = −𝐴𝐴1 𝑒𝑒 −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜1𝑡𝑡 + −𝐴𝐴2 𝑒𝑒 −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜2𝑡𝑡 + 𝐶𝐶

(22)

Rapid mixing of AaCS•OAA with AcCoA-d3 shows an even larger initial rise in
fluorescence emission intensity (21% recovery) relative to reactions lacking AcCoA-d3.
This is followed by a smaller transient fluorescence rise (Figure 4.12 inset). Qualitatively,
there does appear to be a substrate kinetic isotope effect on both observed kinetic
phases.
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Table 4.3. Summary of fitted parameters from SFF studies mixing AaCS•OAA with a substoichiometric concentration (1.5 µM) of AcCoA-h3.
Parameter

Value

A1 (%)

1.0 ± 0.3

kobs1 (s-1)

200 ± 40

A2 (%)

-1.5 ± 0.3

kobs2 (s-1)

54 ± 8

C

80.70 ± 0.02

Figure 4.12. Reaction of AaCS•OAA with sub-stoichiometric AcCoA-h3 or AcCoA-d3 (1.5
µM) monitored by SFF. AaCS (10 µM) was pre-equilibrated with 200 µM OAA in syringe 1
and was rapidly mixed with 200 µM OAA + 1.5 µM AcCoA-h3 (black circles). A control
reaction lacking AcCoA was also done to show the baseline OAA quenched fluorescence
(open circles). The solid red line is a fit to a double exponential and the fitted parameters
are given in Table 3. To determine if there is a substrate kinetic isotope effect, parallel
experiments containing 1.5 µM AcCoA-d3 were done (open triangles in the inset).
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Condensation can be rate-limiting for AaCS.
Steady-state kinetics of TpCS and AaCSH6 were monitored in H2O or D2O as a
function of [AcCoA-(d3)] with saturating OAA (Figures 13 and 14, respectively). Each data
set was fit to the Michaelis-Menten equation to determine Vmax and KM (Table 4). These
values were used to determine KIEs for TpCS and AaCS (Table 5). TpCS displayed a small
substrate KIE on V/K with no effect on the maximal rate (Figure 12A) and solvent isotope
effect of around 2 for both deuterated and protonated substrates. This is consistent with
earlier reports that indicate TpCS is almost entirely rate limited by hydrolysis so no
substrate isotope effect was expected (Kurz et al., 2000; Kurz et al., 2009). However, AaCS
displays comparatively larger substrate KIE on both Vmax and V/K with the largest effect
on V/K of AcCoA-d3 in D2O (Table 4.5). AaCS has a substantially larger substrate KIE
observed in D(Vmax/KM): 2.7 relative to 1.3 for TpCS (Table 5). These data suggest that
removal of a deuteron (i.e., not hydrolysis) is at least partially rate-limiting in steady-state
conversion of AcCoA-d3 by AaCS.
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Figure 4.13. Steady-state kinetic characterization of TpCS. Initial velocities were measured
with either AcCoA-h3 (black circles) or AcCoA-d3 (open circles) at saturating OAA. Panel
A shows data obtained in H2O and panel B shows data obtained in D2O. Steady-state
kinetic parameters are listed in Table 4.
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Figure 4.14. Steady-state kinetic characterization of AaCSH6. Initial velocities were
measured with either AcCoA-h3 (black circles) and AcCoA-d3 (open circles) at saturating
OAA. Panel A shows data obtained in H2O and panel B shows data obtained in D2O.
Steady-state kinetic parameters are listed in Table 4.

146

Table 4.4. Steady-state kinetic parameters for TpCS and AaCSH6 obtained in
H2O or D2O.
TpCS

AaCSH6

Vmax (units/mg)

12.7 ± 0.5 (H2O)
7.1 ± 0.2 (D2O)

202 ± 6 (H2O)
121 ± 2 (D2O)

kcat (s-1)

9.5 ± 0.4 (H2O)a
5.3 ± 0.1 (D2O)

171 ± 5 (H2O)b
102 ± 2 (D2O)

KM (µM)

3.0 ± 0.4 (H2O)c
1.6 ± 0.2 (D2O)

26 ± 3 (H2O)d
12 ± 1 (D2O)

kcat/KM (µM-1 s-1)

3.2 ± 0.4 (H2O)
3.3 ± 0.4 (D2O)

6.6 ± 0.8 (H2O)
8.5 ± 0.7 (D2O)

Vmax (units/mg)

12.8 ± 0.7 (H2O)
5.5 ± 0.5 (D2O)

150 ± 10 (H2O)
135 ± 2 (D2O)

kcat (s-1)

9.5 ± 0.5 (H2O)
4.1 ± 0.4 (D2O)

127 ± 8 (H2O)
114 ± 2 (D2O)

KM (µM)

4.0 ± 0.7 (H2O)
1.5 ± 0.5 (D2O)

60 ± 10 (H2O)
12 ± 0.9 (D2O)

kcat/KM (µM-1 s-1)

2.4 ± 0.4 (H2O)
2.7 ± 0.9 (D2O)

2.1 ± 0.4 (H2O)
9.5 ± 0.7 (D2O)

AcCoA-h3 substrate

AcCoA-d3 substrate

Reported to be 9.2 s-1 (Kurz et al., 2000).
b Reported to be 90 s-1 (Francois et al., 2006). There is substantial variation in k
cat
for AaCS, TpCS (Kurz et al., 2000), and other CS enzymes.
c
Reported to be 0.67 µM (Kurz et al., 2005).
d
Reported to be 29 µM (Francois et al., 2006).
a
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Table 4.5. Substrate and solvent kinetic isotope effects on TpCS and AaCSH6.
TpCS

AaCSH6

DV
max

1.0 ± 0.1 (H2O)a
1.3 ± 0.1 (D2O)a

1.3 ± 0.1 (H2O)
0.90 ± 0.02 (D2O)

D(V
max/KM)

1.3 ± 0.3 (H2O)
1.2 ± 0.4 (D2O)

3.1 ± 0.7 (H2O)
0.9 ± 0.1 (D2O)

D2OV

1.8 ± 0.1 (AcCoA-h3)b
2.3 ± 0.2 (AcCoA-d3)c

1.7 ± 0.1 (AcCoA-h3)
1.1 ± 0.1 (AcCoA-d3)

1.0 ± 0.2 (AcCoA-h3)
0.9 ± 0.3 (AcCoA-d3)

0.8 ± 0.1 (AcCoA-h3)
0.20 ± 0.05 (AcCoA-d3)

max

D2O(V

max/KM)

a Reported

to be 1.17 in both H2O and D2O (Kurz et al., 2000).
Reported to be 2.41 (Kurz et al., 2000).
c
Reported to be 2.33 (Kurz et al., 2000).
b

4.4

Discussion

The formation of citrate catalyzed by CS requires a Claisen/aldol condensation
reaction followed by hydrolysis of the CitCoA intermediate. Together, these reactions
require three chemical steps: proton transfer that forms a reactive carbanion at the
terminal methyl group of AcCoA, condensation with the polarized carbonyl of OAA
forming CitCoA, and finally hydrolysis which releases the products citrate and CoA.
Studying these partial reactions has been difficult by traditional mutagenesis studies
because many of the active site residues are thought to participate in both condensation
and hydrolysis. The AcCoA substrate analogue AcMX has been previously shown to
undergo condensation without subsequent hydrolysis in TpCS (Kurz et al., 2009).
However, since TpCS efficiently converts AcMX to CitMX, proton transfer is not isolated
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from condensation. While HDX implies carbanion formation, it is unclear if AcMX HDX
catalyzed by TpCS•OAA occurs when the enolate is formed or during reverse
condensation. We report here that AaCS is the ideal form of CS to study proton transfer
because AaCS stabilizes the ternary complex over condensation while undergoing rapid
HDX.
Proton transfer without condensation.
In CS forms containing a reporter Trp the reaction chemistry can be readily
monitored. Proton transfer may be monitored without the complication of condensation
in PCS but PCS lacks a suitable reporter Trp (Kurz et al., 2009). A steady-state fluorescence
change is not expected if proton transfer is occurring without condensation but a reporter
Trp allows detection of any transient formation of CitMX.
In AaCS Trp400 reports on OAA binding. Despite extensive primary sequence
divergence and quaternary structural differences the active sites of AaCS and TpCS are
structurally similar. Like TpCS, fluorescence quenching is caused by proximity of a
polarized OAA carbonyl to Trp400 upon binding to AaCS. Therefore, any fluorescence
“dequenching” upon binding to AcMX would be assumed to be caused by condensation.
Addition of AcMX to TpCS•OAA alleviates most of the fluorescence quenching due to
destruction of the OAA carbonyl during condensation. However, incubating AaCS•OAA
with AcMX in H2O does not form any detectable CitMX. Interestingly, titrating AaCS•OAA
(pre-exchanged) with AcMX-d3 in D2O does result in a saturating fluorescence change
(Figure 6). The cause of the fluorescence change is unclear but because AaCS•OAA
is further quenched upon binding AcMX-d3, the formation of CitMX is unlikely.
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SFF studies of AaCS•OAA binding to AcMX-(d3) indicate that if CitMX is forming
it is extremely transient and would have to occur in the deadtime of the instrument. A
very small monophasic increase in fluorescence was observed and may be a
consequence of AcMX carbanion formation, reducing the effective positive potential at
the OAA carbonyl carbon, or, less likely, a limited amount of CitMX formation. Another
potential reason for the difference is the use of a high-pass optical filter for SFF and a
monochromator for titration experiments. There is no concentration dependence on the
observed rate constants but the amplitude of the fluorescence change does appear to
saturate at high AcMX-d3 concentrations with an apparent binding affinity that is similar
to the Kd observed by steady-state titrations (Table 4.1).
AaCS•OAA catalyzes HDX without condensation.
HDX at the terminal methyl group of AcMX catalyzed by AaCS is direct evidence
that proton abstraction must occur. Deuterium incorporation can be directly monitored
by NMR and mass spectrometry. Under the same reaction conditions (pD 7.9, 25 °C), AaCS
catalyzes AcCoA-dependent turnover at about four times the rate of HDX measured by
NMR or ESI-MS. These differences in rates are consistent with what is observed in TpCS
which catalyzes AcCoA-dependent turnover at about five times the rate of HDX (Kurz et
al., 2009).
HDX does not need to be kinetically competent for AcCoA-dependent turnover.
It is possible that enolization is much faster than deuteron addition. If the ternary
complex forms and dissociates faster than the rate of HDX observed by NMR then not
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every ternary complex that forms will result in an HDX event. Moreover, rapid and
reversible ternary complex formation would allow the dissociated AcMX isotopomer to
equilibrate with bulk AcMX, leading to HDX that is distributive in nature (Figure 4.15). In
contrast, if the lifetime of the ternary complex is long relative to the time required for
methyl group rotation and HDX, multiple HDX events could occur prior to AcMX
dissociation. These circumstances would lead to HDX that is processive in nature (Figure
4.15). In distributive HDX, D1 is the only isotopomer product formed early in the HDX
reaction, without an initial lag phase (Figure 4.8). The other isotopomer products will be
formed in succession, with distinct lag phases. In contrast, a processive HDX process
yields some of each deuterated isotopomer product (D1–D3) at early times during the
reaction. Even though the introduction of deuterium atoms leads to chemical shift
changes in the remaining methyl protons, the overlapping signals mean it is difficult to
distinguish between distributive and processive HDX models by NMR.
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Figure 4.15. Kinetic models for CS•OAA-catalyzed AcMX HDX shown as a Cleland-type
diagram. The processive model predicts initial formation of multiple isotopomers (with
abundance D1 > D2 > D3, but with all progress curves increasing from t = 0). The
distributive model predicts initial formation of only D1, with lags in the production of D2
and D3. All dissociation steps (upward arrows) are presumed to result in equilibration
with the bulk AcMX isotopomer pool and are therefore effectively irreversible.
ESI-MS analysis allowed the quantitation of individual AcMX isotopomers and was
used to distinguish between the two possible models for HDX of AcMX catalyzed by
AaCS•OAA. This technique confirmed a distributive model of HDX, meaning that no more
than one exchange event (including silent D→D exchanges accounted for by geometric
selection factors) occurs prior to dissociation of AcMX from the ternary complex. This
model is consistent with the observation that HDX is slower than AcCoA-dependent
turnover but does not identify the step in which HDX is occurring.
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Pre-steady-state kinetic analysis is consistent with a distributive mechanism for HDX.
The apparent binding affinity determined by SFF is in good agreement with
binding constants determined by steady-state fluorescence titrations of AaCS•OAA with
AcMX or AcMX-d3. However, from these data it is not possible to determine if pre steadystate kinetics follow a simple one step binding model or a two-step binding model with
rapid pre-equilibrium followed by a slower isomerization step. The off rates estimated by
either model are consistent with distributive HDX of AcMX.
Rapidly mixing AaCS•OAA with AcMX-d3 in D2O best matches the conditions used
to determine the rate of HDX by NMR. The SFF kobs values are independent of AcMX-d3
concentration and have an average value of ~200 s-1 in D2O. Using this observed and the
apparent binding affinity of 12 µM the upper and lower limit for the off rate can be
estimated for both a one-step and two-step binding model. Since HDX requires ACMX
isotopomer dissociation, the lower limit of the off rate (koff) is simply the rate of HDX
determined by NMR (18 s-1). The off rate determined with a one-step binding model (Eqn
22) is ~90 s-1.

𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 =

𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜

[𝐿𝐿]

1+𝐾𝐾

(23)

𝑑𝑑

The ratio of the measured binding affinities by SFF (Kd1 = 12 µM) and steady-state
titration (Kd1Kd2 = 6 µM) indicate that k2 must be twice k-2 in a two-step binding model.
In this model, kobs = k2 + k-2 and considering the average kobs in D2O is ~200 s-1, k2 must
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be ~130 s-1. The lower limit of koff in a two-step binding model can be estimated
considering koff must be faster than k2 for rapid equilibrium to occur. Therefore koff must
be at least 130 s-1.
If the binding model is more complex, the off rate must still be less than the
observed rates of ~200 s-1. In both cases the calculated rate of AcMX dissociation is faster
than the observed rate for HDX suggesting that every AcMX (isotopomers D0 – D2)
binding event does not result in HDX. These estimations are consistent with the
distributive HDX pattern directly observed by ESI-MS.
The probability of proton exchange can be estimated for one-step or two-step
binding models by taking the ratio of the observed rate of HDX from NMR (18 s-1) and the
off rates estimated above. In the case of a one-step binding model, 20% of binding events
result in proton exchange and 14% of binding events result in proton exchange in a twostep binding model.
The condensation reaction has the potential to be rate-limiting for AaCS.
AcMX-d3, in which the terminal methyl group is fully deuterated and unable to
undergo uncatalyzed exchange with solvent H2O, was used to detect any substrate KIEs.
These reactions were also monitored in D2O to detect any solvent KIEs. Steady-state
turnover in TpCS has a negligible substrate KIE, which is not surprising considering that
hydrolysis is rate-limiting (Kurz et. al., 2000). However, AcCoA-dependent turnover
catalyzed by AaCS•OAA does have a substrate KIE, D(Vmax/KM), which indicates that
hydrolysis is not rate-limiting. These data suggest that the condensation reaction
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catalyzed by AaCS can be made at least partly rate limiting in the steady-state by
deuterium substitution.
The ternary AaCS•OAA•AcMX complex is favored over the binary AaCS•CitMX complex.
TpCS stabilizes the binary condensation product TpCS•CitCoA relative to the precondensation ternary complex whereas PCS stabilizes both complexes to a similar extent
(Kurz et al., 2009). The preponderance of the evidence obtained with TpCS furthermore
suggests that the dead-end complex TpCS•CitMX is preferentially stabilized relative to the
Michaelis complex analogue TpCS•OAA•AcMX. HDX in AcMX catalyzed by AaCS•OAA
occurs without detectable condensation, which suggests that different CS forms have
different on-enzyme equilibria. These conclusions are illustrated best by a schematic
depiction of a portion of the complete overall free energy reaction profile below (Figure
4.16) (Kurz et al., 2009).
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Figure 4.16. Schematic free energy reaction profiles of the condensation reaction
catalyzed by CS. The full TpCS and partial PCS profiles are based on measurements with
real substrates, not the substrate analogue AcMX, and are quantitatively described in Kurz
et al., 2009. The free energy of each ternary complex is arbitrarily set to 0 indicating that
anything below that is more stable for a given enzyme form (ΔG < 0). The partial dashed
line indicates that is it unlikely that each enzyme has the same kinetic barrier (ac). SFF
studies suggest that AaCS does not form a binary complex with CitMX to a significant
extent. If this also applies to the reaction of AaCS•OAA with AcCoA, AaCS appears to
stabilize the ternary complex relative to the binary condensation product. PCS stabilizes
both complexes to a similar extent, and TpCS preferentially stabilizes the binary
condensation product.
Preliminary AaCS•OAA + AcCoA-h3 single turnover reactions.
For the binding of AcCoA-h3/AcCoA-d3 to TpCS•OAA, two kinetic phases are
observed during single turnover reactions. The first being a rise in fluorescence
correspond to destruction of the polarized OAA carbonyl (this reports on a combination
of proton transfer and condensation) and the second being a drop in fluorescence back
to OAA quenched baseline (this reports on a combination of hydrolysis of CitCoA and
dissociation followed the rapid binding of unreacted excess OAA) (Kurz et al., 2009).
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Preliminary AaCS•OAA + AcCoA-h3 single turnover reactions were performed.
The chemical steps corresponding to the observed fluorescence changes are currently
unclear. AaCS appears to have a fast phase occurring during the instrument dead-time
using both AcCoA-h3 and AcCoA-d3 substrates that is missing for TpCS (Kurz et al., 2009).
The cause of this fluorescence change is currently unknown. The fast phase was followed
by a second, observed, kinetic phase with a kobs1 = 200 s-1. The third and slowest kinetic
phase (kobs2 = 54 s-1) is too slow to be kinetically competent in steady-state catalysis
(171 s-1, Table 4.1). There are significant differences observed here between AaCS and
TpCS and these experiments should be repeated.
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APPENDIX

Supplementary Methods
AaCSFl
The procedure used to isolate AaCSintein from BL21(DE3) cells transformed with pJK240
was followed as previously described up to the chitin column step, except that buffer J
(50 mM , pH 8.0, 500 mM KCl, and 1 mM EDTA) was used instead of buffer H to equilibrate
the chitin column and to perform protein buffer-exchange (Francois et a., 2006). After
washing the chitin column (2.5 cm × 6 cm, 24 mL) with 3 column volumes (CV) of buffer
J, the column was flushed with 3 CV of buffer J containing 50 mM sodium 2-

mercaptoethanesulfonate (MESNA). After 48 h at 4 ∘C, the column was developed with 3
CV

buffer

J.

Fractions

containing

protein

were

pooled,

concentrated

by

ultracentrifugation (Amicon YM-30 Centriprep centrifugal filter device), and bufferexchanged to dilute MESNA to < 10 𝜇𝜇M. A solution of 3 mM 1 in buffer K (50 mM , pH 8.0,

100 mM KCl) (1 mL) was added to three Eppendorf tubes, each containing AaCS- MESNA
(15.6 mg mL-1 in 0.22 mL buffer J); a 1:42 ratio of AaCS-MESNA:1 was present upon mixing.
After 48 h at 4 ∘C, the reaction mixtures were combined and subjected to three cycles of

dilution-reconcentration in buffer K. The concentrated AaCSFl solution (0.2 mL) was
diluted into buffer K plus 20 mM 2-mercaptoethanol (𝛽𝛽ME, 2 mL). After 24 h at 4 ∘C,
dilution-reconcentration in buffer K (five cycles) was used to dilute 𝛽𝛽ME to < 10 𝜇𝜇M. The
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concentrated protein was applied to a Sephadex G25 column (2.5 cm × 33 cm, 130 mL)

equilibrated and then developed in buffer K. Fractions containing protein were combined,
concentrated, and diluted-reconcentrated in buffer K plus 10 mM 𝛽𝛽ME.

Solutions containing AaCSFl appeared orange under visible illumination and green- yellow
under UV illumination (302 nm). Single-use aliquots (13.7 mg mL-1) were frozen and
stored at −80 ∘C. As a control, AaCS-MESNA derivatized with N-2-[(fluorescein-5-

carbonyl)amide]ethyl-L-cysteinamide was buffer-exchanged in the absence of 𝛽𝛽ME. The

major ESI-MS peak obtained was consistent with AaCS(Fl)2. Excess, unreacted N-2-

[(fluorescein-5-carbonyl)amide]ethyl-L-cysteinamide therefore appears to form a
heterodisulfide with a single accessible cysteine per AaCS(Fl) subunit.
Tables
Table A1. Oligodeoxynucleotides used in this study.a

a

name
898

mutant
W404F

strand
coding

899

W404F

non-coding

959

W400F

coding

960

W400F

non-coding

Positions that alter the original sequence are underlined.

sequence (5′ → 3′)
GGCTGGGTGAGCCAG
TAAGGAAATGATTGA
AGAA
TTCTTCAATCATTTCCT
TACTGGCTCACCCAGC C
CCGCACCACCGGCTG
TGAGCCAGT
ACTGGCTCACAGCCG
GTGGTGCGG

Determination of FRET efficiencies for various AaCSFl complexes.
Crystal structures of unliganded (PDB id 1k3p), the binary complex (PDB id 4jag), and the
ternary complex (PDB id 2h12) show that the C-terminal residue is 25–30 Å from either
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Trp400’ or Trp404’, regardless of what ligands are present (17, 24, 27). Trp-Fl Förster
distances measured with unliganded and various ligand-bound forms of AaCSFl (Table 3)
were similar, with an average 𝑟𝑟�𝐴𝐴 = 33 Å. This 𝑟𝑟�𝐴𝐴 value is in the expected range, given

that a fully extended Fl-tag is 10 Å long.

Table A2. Determination of FRET efficiencies for various AaCSFl complexes.
additionsa

ƒAaCS (M-1)

ƒAaCSFl (M-1)

E

ṙDA (Å)

none

2.23 x 108

1.91 x 108

0.257

32.2

OAAb

1.84 x 108

1.47 x 108

0.365

29.6

OAA+CMXb,c

1.59 x 108

1.42 x 108

0.190

34.4

OAA+AcMXb,d

1.64 x 108

1.46 x 108

0.199

34.1

Conditions: excitation wavelength, 295 nm; emission wavelength, 346 nm
temperature, 25 C; 50 mM potassium phosphate, pH 8.0, 100 mM KCl; final
sample volume, 2.5 mL.
b
OAA was added to a final concentration of 0.1 mM. Emission intensities
have been corrected for inner filter effect due to OAA.
c
CMX was added to a final concentration of 0.11 mM. No inner filter effect
correction was necessary for CMX.
d
AcMX was added to a final concentration of 0.13 mM. No inner filter effect
correction was necessary for AcMX. The excitation slit width was 2.5 nm.
a
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Supplementary Figures

Figure A1. OAA fluorescence titration data recorded in 50 mM potassium phosphate, pH
8, 100 mM KCl containing 0.425 mM AaCSFl at 25 °C (excitation: 296 nm; emission: 340
nm). The solid line is a fit of the data to a single binding site (Table 1).
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Figure A2. Spectroscopic characterization of AaCSFl in buffer PK8. (A) Absorbance
spectra of AaCS (dotted line) and AaCSFl (solid line) with each scaled to 1 mg mL�1 (21
mM subunits). (B) AaCSFl fluorescence excitation (dotted line) and emission (solid line)
spectra. The excitation and emission spectra were recorded with emission and
excitation wavelengths of 339 nm and 295 nm, respectively.
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Figure A3. Analysis of AcMX by HPLC. The areas of the indicated peaks correspond to a
5:1 ratio of AcMX:iso-AcMX.
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